A quantitative compendium of COVID-19 epidemiology
Yinon M. Bar-Onâ€‹1*â€‹, Ron Senderâ€‹1*â€‹, Avi I. Flamholzâ€‹2â€‹, Rob Phillipsâ€‹3,4â€‹, Ron Miloâ€‹1
1â€‹
Weizmann Institute of Science, Rehovot 7610001, Israel
2â€‹
University of California, Berkeley, CA 94720, USA
3â€‹
California Institute of Technology, Pasadena, CA 91125, USA
4â€‹
Chan Zuckerberg Biohub, 499 Illinois Street, SF CA 94158, USA
* Equal contribution
Abstract:
Accurate numbers are needed to understand and predict viral dynamics. Curation of high-quality
literature values for the infectious period duration or household secondary attack rate, for
example, is especially pressing currently because these numbers inform decisions about how and
when to lockdown or reopen societies. We aim to provide a curated source for the key numbers
that help us understand the virus driving our current global crisis. This compendium focuses
solely on COVID-19 epidemiology. The numbers reported in summary format are substantiated by
annotated references. For each property, we provide a concise definition, description of
measurement and inference methods, and associated caveats. We hope this compendium will
make essential numbers more accessible and avoid common sources of confusion for the many
newcomers to the field such as using the incubation period to denote and quantify the latent
period or using the hospitalization duration for the infectiousness period duration. This document
will be repeatedly updated and the community is invited to participate in improving it.

Structure of the document
For each property covered in the current compendium, we present a set of curated studies from the
literature best suited for estimating the specific property. For each study we provide an excerpt
containing the estimate, to allow full transparency regarding the source of the estimate. Within each
excerpt we use bold typeface to guide the readersâ€™ attention to the relevant estimate. In addition to
presenting the curated set of studies, we also provide a best estimate for each property.
Synthesizing estimates provided by all available studies into a singular quantity is challenging
because different studies rely on different methodologies for measuring and estimating the
property of interest, and thus each has its own associated biases and caveats. In our analysis, we
do not attempt to rigorously assess the credibility of each study, but rather provide a best estimate
which is the result of our judgement after reading the relevant background material.

1

Figure 1: Key epidemiological properties of COVID-19 and their corresponding numerical values.
Further details are provided in the following dedicated subsections. All graphs are schematics and
not data. Some values represent population-level median and do not describe inter-individual
variability, which is substantial.

2

Table of contents:
Latent period duration

4

Infectious period duration

6

Incubation period duration

8

Serial interval / Generation interval

10

Doubling time and exponential growth rate

14

Basic reproduction number

16

Effective reproduction number

20

Dispersion of the secondary infection distribution

24

Fraction of asymptomatic infections

27

Household secondary attack rate

30

Case fatality rate (CFR)

31

Infection fatality rate (IFR)

32

Probability of hospitalization

34

Probability of ICU admission

37

Probability of death in ICU

39

RT-qPCR False Positive Rate

41

RT-qPCR False Negative Rate

43

Duration of PCR positivity

46

Antibody Test False Positive Rate

47

Antibody Test False Negative Rate

48

Knowledge gaps

50

References

51

3

Latent period duration
Definitionâ€‹: Time between infection and the onset of infectiousness. Because this time varies from
patient to patient, it is best characterized by a distribution, as shown in the figure.
Best estimateâ€‹: 3
â€‹ -4 days (population average, inter-individual variation is substantial)
Methods of measurement and estimationâ€‹: To calculate the latent period, we would ideally like to
know the timing of infection and the time-dependent infectiousness profile for a large number of
people. Individual profiles could then be combined to calculate an infectiousness profile
(infectiousness as a function of time since infection) for COVID-19. The infectiousness profile is a
continuous distribution, so the latent period can then be defined as the time interval that must pass
before half-maximal infectiousness. The two main methods of estimating the duration of the latent
and infectiousness periods durations are i) use of known infector-infectee pairs, and ii) fitting
epidemiological compartmental models.
Estimatesâ€‹:
â— Epidemiological models (for early stages in China):
â—‹ (Li et al. 2020)â€‹ - â€â€‹ In addition, the median estimates for the latent and infectious periods
are approximately 3
â€‹ .69â€‹ and 3.48 days, respectively.â€‹â€ Table S1 â€œâ€‹Latency period (Z, days)
(95% CIs) (3.48, 3.90)â€‹â€
â—‹ (Tian et al. 2020)â€‹ - Table 3. The table reports an incubation period of 4
â€‹ .9 d
â€‹ ays â€‹(â€‹4.32 to
5.47 95% CI). However, the value presented in the table actually represents the latent
period and is mistakenly called the incubation period.
â— Infector-Infectee pairs
â—‹ 77 pairs from China: (â€‹ He et al. 2020)â€‹ - Figure 1C reports the infectiousness profile as a
function of days from symptom onset. We use the time it takes the infectiousness to
reach half its peak, which happens two days before symptom onset. As symptoms
arise after 5 days (see incubation period), this means the latent period is about â€‹3 d
â€‹ ays.
â—‹ 11 pairs from several countries (â€‹ Ma et al. 2020)â€‹ - â€œâ€‹ The mean and standard deviation
were 7.44 days and 4.39 days for incubation period, â€‹2.52 d
â€‹ ays and 3.95 days for the
upper limit of latent periodâ€‹â€
Caveatsâ€‹:
â— Epidemiological models usually use the dynamics of the epidemic to infer a population-level
characteristic (e.g. median or mean). The structure of the model inherently determines the
distribution of the latent period. For example, in the standard SEIR model, the latent period is
assumed to be exponentially distributed.
â— Simple SEIR-type models assume infectiousness onset occurs at a specific time, before which
a person is not infectious and after which they become fully infectious. A more realistic
scenario is that infectiousness increases gradually throughout the infection progression, and
thus the definition of the latent period is harder to nail down. We use the time until half
maximal infectiousness as the definition for the latent period in infector-infectee pair data.
â— When estimating the population median latent period from infector-infectee pairs, there is an
inherent assumption that the infectiousness profile of different people is similar. Even though
this assumption does not fully capture the variability between individuals for example based
on their age or based on the state of their immune system, it is a conscious choice made to
reduce the complexity of the models, and results in an effective value that averages across
this variability.

4

â—

There is often confusion in the literature between the latent period and the incubation period,
the latent period being the time before the onset of infectiousness and the incubation period
being the time before onset of symptoms. Many manuscripts refer to the properties of the
latent period but write it as the incubation period or use the value of the incubation period to
describe the latent period.

5

Infectious period duration
Definitionâ€‹: Characteristic duration over which a person is infectious.
Best estimateâ€‹: 4
â€‹ -5 days (population average, inter-individual variation is substantial)
Methods of measurement and estimationâ€‹: The two main methods for estimating the duration of
infectiousness is (i) use of data from infector-infectee pairs, and (ii) fitting epidemiological
compartmental models. When using data reported by infector-infectee pairs, it is difficult to
determine the exact time of infection. Instead, patient-reported timing of symptom onset is used to
determine the lag between infector symptoms and infectee symptoms, also known as the serial
interval (see â€œâ€‹Serial interval/Generation intervalâ€‹â€ section). This data is combined with independent
data on the distribution of incubation periods (the time from infection to symptom onset), to infer a
distribution of generation intervals (time from infection of the infector to the infection of the infectee).
As it quantifies the probability of transmission per day post infection, the distribution of generation
intervals is also commonly used to infer an â€œinfectiousness profileâ€ for infected patients. The
difference between the generation interval distribution and the infectiousness profile is that the first
represents a distribution of the probability of a secondary infection after a given time interval since
the first infection, while the other represents a distribution of those transmission rates. Therefore, the
integral of the generation interval distribution is by definition equal to one, while the integral of the
infectiousness profile is the reproduction number Râ€‹tâ€‹. Thus, to convert the distribution of the
generation intervals into an infectiousness profile, it is scaled by the average reproduction number
(Ferretti et al. 2020)â€‹. As this is a continuous distribution, there isnâ€™t a single â€œinfectious periodâ€ value,
but one can define the interval between half the maximal infectiousness as a measure indicative of
the infectious period duration. Alternatively, the infectious period can be inferred by fitting
epidemiological compartmental models as these models relate the (unknown) infectious period to
reported counts of cases and deaths.
Estimatesâ€‹:
â—

â—

Infector-Infectee pairs
â—‹ (77 pairs from China): (â€‹ He et al. 2020)â€‹ - Figure 1C reports the infectiousness profile as
a function of days from symptom onset. We quantify the interval between the time
points of half the maximal infectiousness based on the infectiousness profile, which is
about 4
â€‹ â€‹days.
â—‹ (44 pairs from various countries): (â€‹ Ferreti et al. 2020)â€‹ - â€œâ€‹The distribution is best
described by a Weibull distribution (AIC=148.4, versus 149.9 for gamma and 152.3 for
lognormal distribution) with mean and median equal to 5
â€‹ .0 â€‹days and standard deviation
of 1.9 daysâ€‹â€. The infectiousness profile has the same distribution as the generation
time distribution.
Epidemiological compartmental models (for early stages of the epidemic in China):
â—‹ (Li et al. 2020)â€‹ - â€â€‹In addition, the median estimates for the latent and infectious periods
are approximately 3.69 and 3
â€‹ .48 d
â€‹ ays, respectively.â€‹â€ Table S1 â€œâ€‹Infectious period for
documented infections (Dr , days) (95% CIs) (3.26, 3.67) â€‹â€
â—‹ (Tian et al. 2020)â€‹ - Table 3. The table reports â€‹5.1 d
â€‹ ays long infectious period â€‹(4
â€‹ .51 to
5.86 95% CI)

6

Caveatsâ€‹:
â— Interventions will affect the duration of the infectious period. For example, isolation of
infected individuals with symptoms limits their chances to infect non-household members.
This reduces the overall number of infections, and shortens the time in which such infections
occur, and hence the infectious period duration.
â— Epidemiological compartmental models usually use the dynamics of the epidemic to infer the
population-level characteristic (e.g. median or mean). The structure of the model inherently
determines the distribution shape for the infectious period. For example, in the simple
Susceptible-Exposed-Infectious-Recovered (SEIR) model, the distribution of the infectious
period is assumed to be exponential.
â— Simple SEIR-type models assume infectiousness is constant throughout the infectious period,
and that the start and end of infectiousness occurs abruptly. A more realistic scenario is that
infectiousness increases gradually throughout the progression of the infection and then
decreases. In this scenario, the semantics of the infectious period is harder to define. We use
the duration in which a person has infectiousness higher than half of the maximal
infectiousness as the definition for inference of the infectiousness period from
infector-infectee pairs data.
â— When estimating the population average infectious period from infector-infectee pairs, there is
an inherent assumption that the infectiousness profile of different people is similar. Even
though this assumption does not fully capture the variability between individuals for example
based on their age or based on the state of their immune system, it is a conscious choice
made to reduce the complexity of the models, and results in an effective value that averages
across this variability.
â— One should be careful not to confuse the infectious period duration with the time from
infection until someone can be infected. There is a latent period duration that adds to the
infectious period and together these two distributions determine the time from being infected
until infecting others. In addition, there is also wide variation among cases in their
infectiousness profile, so the infectious period duration should be used as a statistical value
rather than the maximal date after which people stop being contagious.
â— Another source of confusion is usage of the duration of illness or hospitalization as the
duration of infectious period. The infectious period is much shorter than the overall duration
of illness (which is often on the order of a few weeks). People's illness is usually prolonged
due to the inflammatory response of the immune system. Thus people usually stop being
strongly contagious well before they recover from the disease. The dynamics of the epidemic
is governed by the infectious period and not by the time of overall illness duration.

7

Incubation period duration
Definitionâ€‹: Time from infection until onset of symptoms in symptomatic cases.
Best estimateâ€‹: 5
â€‹ -6 days (population average, inter-individual variation is substantial)
Methods of measurement and estimationâ€‹: There are two main methods for estimating the incubation
period of COVID-19. The first is based on investigation of possible exposure times for reported cases.
This usually entails collecting information on possible exposure time for a set of cases, and
combining this information with records of the onset of symptoms. A statistical model is used to fit
the data with a possible distribution of incubation times. The second method is based on
epidemiological models. In this approach, exponential growth is used to model the dynamics of the
epidemic, and a certain functional form is assumed for the distribution of the incubation period. The
observed number of cases is a combined result of viral transmission (the output of the exponential
growth model), and the distribution of incubation period (causing an infected person to show
symptoms and thus be detected as a case). The model parameters, both for the exponential growth
model, (similar to those described in the effective reproduction number section) as well as for the
incubation period, are inferred such that the modelâ€™s projections match case data as closely as
possible.
Estimatesâ€‹:
â— Investigation of the possible time for reported cases
â—‹ 181 cases outside Hubei: â€‹(Lauer et al. 2020)â€‹ - â€œâ€‹The median incubation period was
estimated to be â€‹5.1 d
â€‹ ays (95% CI, 4.5 to 5.8 days), and 97.5% of those who develop
symptoms will do so within 11.5 days (CI, 8.2 to 15.6 days) of infection. These estimates
imply that, under conservative assumptions, 101 out of every 10 000 cases (99th
percentile, 482) will develop symptoms after 14 days of active monitoring or
quarantine.â€‹â€
â—‹ 10 cases in Wuhan: â€‹(Li et al. 2020)â€‹ - â€œâ€‹The mean incubation period was 5
â€‹ .2 â€‹days (95%
confidence interval [CI], 4.1 to 7.0), with the 95th percentile of the distribution at 12.5
daysâ€‹â€.
â—‹ 88 cases of travellers from Wuhan (â€‹ Backer et al. 2020)â€‹ - â€œâ€‹The Weibull distribution
provided the best fit to the data (â€‹Table 1â€‹). The mean incubation period was estimated to
be 6
â€‹ .4 â€‹days (95% credible interval (CI): 5.6â€“7.7).â€‹â€
â—‹ 158 residents from and outside Wuhan â€‹(Linton et al. 2020)â€‹ - â€œâ€‹The mean incubation
period was estimated at 5
â€‹ .0 d
â€‹ ays (95% credible interval [CI]: 4.2, 6.0) when excluding
Wuhan residents (n = 52) and 5
â€‹ .6 â€‹days (95% CI: 5.0, 6.3) when including Wuhan
residents (n = 158).â€‹â€
â—‹ 22 patients from South Korea (â€‹ Ki et al. 2020)â€‹ - â€œâ€‹The average incubation period was â€‹3.9
days (median, 3.0)â€‹â€
â—‹ 50 global cases â€‹(Jiang et al. 2020)â€‹ - â€œâ€‹The corresponding mean and 95% CI were:
SARSâ€CoVâ€2, â€‹4.9â€‹ (4.4â€5.5) daysâ€‹â€
â—‹ 291 cases in China (â€‹ Guan et al. 2020)â€‹ - â€œâ€‹The median incubation period was 4
â€‹ â€‹days
(interquartile range, 2 to 7)â€‹â€
â—‹ 49 cases from China (â€‹ Zhang et al. 2020)â€‹ - â€œâ€‹We analyzed the time interval from exposure
to illness onset for 49 cases (with no travel history to/from Wuhan/Hubei ) identified by
prospective contact tracing in 37 clusters. We estimated a mean incubation period of
5.2 d
â€‹ ays (95%CI: 1.8-12.4), with the 95th percentile of the distribution at 10.5 daysâ€‹â€

8

93 cases from Guizhou, China â€‹(Ping et al. 2020)â€‹ - â€œâ€‹The median incubation period was
8.06 d
â€‹ ays (95% confidence interval [CI]: 6.89 â€“ 9.36).â€‹â€
â—‹ 91 cases from Zhejiang, China (â€‹ Qian et al. 2020)â€‹ - â€œâ€‹The median of incubation period
was â€‹6â€‹ (IQR, 3-8) daysâ€‹â€
â—‹ 262 cases from Beijing, China â€‹(Tian et al. 2020)â€‹ - â€œâ€‹The median time from contact
symptomatic case to illness onset, which is called the incubation period, was â€‹6.7â€‹ daysâ€‹â€
â—‹ 22 paired cases from Taiwan and mainland China â€‹(Cheng et al. 2020)â€‹ - â€œâ€‹ U
â€‹ sing the data
on the 22 paired cases, we estimated that the median incubation period was 4
â€‹ .1â€‹ days
(95% credible interval [CrI], 0.4-15.8)â€‹â€
â—‹ 587 cases from seven countries â€‹(Ma et al. 2020)â€‹ - â€œâ€‹By pooling individual data from
seven countries, we estimated the mean incubation period of COVID-19 to be 7
â€‹ .44â€‹ daysâ€‹â€
Epidemiological models (for early stages in China): â€‹(Li et al. 2020)â€‹ - â€œâ€‹The mean incubation
period was â€‹5.2 d
â€‹ ays (95% confidence interval [CI], 4.1 to 7.0), with the 95th percentile of the
distribution at 12.5 days.â€‹â€
â—‹

â—

Caveats:
â— There is often confusion in the literature between the latent period and the incubation period,
the latent period is defined as the time before the onset of infectiousness and the incubation
period is defined as the time before onset of symptoms. Many manuscripts refer to the
properties of the latent period but incorrectly identify it as the incubation period or use the
value of the incubation period to describe the latent period.

9

Serial interval / Generation interval
Definition
Generation interval â‰¡ Average time between infection events in an infector-infectee pair.
Serial interval â‰¡ Average time between symptom onsets in an infector-infectee pair.
See Figure 1 for a graphical representation.
The serial interval distribution is a combination of the generation interval distribution with the
incubation period distribution. The expected values of the serial and generation interval distributions
are expected to be equal but their variances are different. The variance of the serial interval equals
the sum of variances of the generation interval and the incubation period, and thus is larger. The
generation interval is more useful for describing viral spread than the serial interval, because it
directly relates to the timing of infection. Unfortunately, this distribution is harder to estimate than the
distribution of serial intervals because people do not typically know when they were infected.
Interventions such as isolation of symptomatic patients and contact tracing could shorten these two
intervals by â€‹replacing lower frequency and shorter duration contact (e.g. at work and social
gatherings) with high-frequency and long duration contact at homeâ€‹. The interventions lower the mean
and median serial interval by censoring the distribution of serial intervals (among the various
infected-infectee couples).
Best estimateâ€‹:
No interventionsâ€‹: 7 days
Isolation of symptomatic patients and contact tracing: â€‹4-5 days
Methods of measurement and estimationâ€‹:
Estimation of the serial interval is based on identification and tracking of chains of transmission.
Identifying the precise moment of infection is challenging, so most researchers use patient-reported
timing of symptom onset, which is available in more cases. Data regarding symptom onset of
identified pairs of infector-infectee is collected through detailed interviews. The delay between the
onset of symptoms of each pair is sometimes used to calculate descriptive statistics (median, mean,
standard deviation) and, in other cases, is used to fit an a priori distributional model.
In order to estimate the generation interval from the serial interval, one must account for the
incubation period because the infector is not infectious during this time. In some sources, symptom
onset timing from infector-infectee pairs is combined with a reported distribution of incubation
periods to estimate the generation time by fitting to a parametric distribution. Iâ€‹n most cases, the fit
distributional parameters are allowed to assume a wide range of values, such that the assumptions
have a minimal effect on the fitâ€‹.

Estimatesâ€‹:
â— Starting of the epidemic :
â—‹ Uncontrolled in Wuhan (china)
â–  6 transmission pairs â€‹ (â€‹ Li et al. 2020)â€‹ â€‹ - â€œâ€‹we estimated that the serial interval
distribution had a mean (Â±SD) of â€‹7.5â€‹Â±3.4 days (95% CI, 5.3 to 19)â€‹â€
â–  43 transmission pairsâ€‹ (Wu et al. 2020b)â€‹ - â€œâ€‹The mean serial interval is â€‹7.0
(5.8â€“8.1) days, with a standard deviation of 4.5 (3.5â€“5.5) daysâ€‹â€.

10

â—‹

Vo, Italy - (â€‹Lavezzo et al. 2020â€‹) - â€œâ€‹ From the inferred transmission pairs, we estimated a
serial interval distribution with mean 6
â€‹ .90 d
â€‹ aysâ€‹ â€‹(95% CI 2.56-13.39) before lockdown
(Figure S7) and 10.12 days (95% CI 1.67-25.90) after the lockdownâ€

â—

Serial interval measured in countries that implemented isolation of symptomatic patients,
physical distancing and contact tracing:
â—‹ Korea - (â€‹ Ki et al. 2020)â€‹ - â€‹â€œâ€‹The mean and median serial interval was estimated to be 6
â€‹ .6
days (range 3-15) andâ€‹ 4.0 â€‹days, respectively, based on data of both first-generation and
second-generation patientsâ€â€‹ â€‹(The mean duration between symptom-onset and
quarantine/isolation was 4.3 days)
â—‹ Hong Kong
â–  21 transmission chains â€‹(S. Zhao, Gao, et al. 2020)â€‹ â€‹-â€‹ â€œâ€‹ Assuming a Gamma
distributed model, we estimated the mean of SI at â€‹4.4 d
â€‹ ays (95%CI: 2.9âˆ’6.7) and
SD of SI at 3.0 days (95%CI: 1.8âˆ’5.8) by using the information of all 21
transmission chains in Hong Kong.â€
â–  171 transmission pairs with 94 unique infectors (â€‹ Adam et al. 2020)â€‹ â€‹-â€‹ â€‹â€œFigure 2A
shows the empirical serial distribution between all infector-infectee pairs and
fitted normal and lognormal distributions. The median serial interval wasâ€‹ 4 â€‹days
(IQR 3 â€“ 8 days), and the meanâ€‹ o
â€‹ f the fitted normal distribution wasâ€‹ 5.6 â€‹days
(standard deviation 4.3 days).â€
â—‹ Singapore and Tianjin (China) - â€‹(Ganyani et al. 2020)â€‹ â€‹- â€œâ€‹ The mean generation time is
estimated to be â€‹5.2 d
â€‹ aysâ€‹ (â€‹ 95%CI, 3.78 - 6.78) for the Singapore data, and â€‹3.95 d
â€‹ ays
(95%CI, 3.01 - 4.91) for the Tianjin dataâ€â€‹.
â—‹ Shenzhen - 4
â€‹ 8 transmission pairs â€‹(Bi et al. 2020)â€‹ - â€œâ€‹ we estimate that the serial interval
is gamma distributed with meanâ€‹ 6.3 â€‹days (95% CI 5.2,7.6) and a standard deviation of
4.2 days (95% CI, 3.1,5.3)â€â€‹.
â—‹ Outside of Hubei province - â€‹468 transmission events (â€‹ Zhanwei Du, Xiaoke Xu, et al.
2020) â€‹- â€œâ€‹ COVID-19 serial intervals seem to resemble a normal distribution more than the
commonly assumed gamma or Weibull distributions , which are limited to positive
values (Appendix). We estimate a mean serial interval for COVID-19 ofâ€‹ 3.96â€‹ (95% CI
3.53â€“4.39) days, with an SD of 4.75 (95% CI 4.46â€“5.07) daysâ€â€‹.
â—‹ Taiwan and mainland China - 2
â€‹ 2 transmission pairs (â€‹ Cheng et al. 2020)â€‹ - â€‹â€œwe estimated
that the median incubation period was 4.1 days (95% credible interval [CrI], 0.4-15.8),
and the median serial interval was 4
â€‹ .1 â€‹days (95% CrI, 0.1-27.8)... A secondary case was
excluded from the paired data if the beginning of exposure was after symptom onset of
the secondary caseâ€.â€‹ They also separate the results between the various regions
(medians: Taiwan=4.1, mainland China=5, other =2.9) and setting (medians:
household=5.2, community:2.9, other=3.3) see supplementary.

â—

Measurement from multiple countries data aggregating effects of their different interventions:
â—‹ China, Japan, Singapore, South Korea, Vietnam, Germany and Malaysia - 689
transmission pairs (â€‹ Ma et al. 2020)â€‹ â€œâ€‹ The serial interval was estimated for 689 pairs of
infector-infectee and ranged from âˆ’5 to 24 days (Table 2), with a median of 6 days. It
was smaller than 0 (mean: âˆ’2.63 days) for 27 (3.92%) pairs, meaning that the infectee
showed symptoms earlier than the infector. Assuming a normal distribution (Figure

11

â—‹

â—‹

â—‹

2(C)), theâ€‹ â€‹mean wasâ€‹ 6.70 d
â€‹ aysâ€‹ â€‹(95% CI: 6.31, 7.10) and standard deviation 5.20 days
(95% CI: 4.91, 5.46).â€
China, Vietnam, Japan, Malaysia, Hong Kong, Taiwan - 77 transmission pairs (â€‹ He et al.
2020)â€‹ â€œserial interval was estimated to have a mean of â€‹5.8 d
â€‹ ays (95% confidence
interval (CI), 4.8â€“6.8 days) and a median ofâ€‹ 5.2 â€‹days (95% CI, 4.1â€“6.4 days) based on a
fitted gamma distribution, with 7.6% negative serial intervalsâ€
Vietnam, South Korea, Germany, Taiwan, Singapore, China - 28 transmission pairs
(Nishiura, Linton, and Akhmetzhanov 2020)â€‹ â€‹- â€œâ€‹ lognormal distribution was selected as
the best-fit model (WAIC = 224.0), while no significant differences from other models
were identified. The median serial interval was estimated at â€‹4.0 d
â€‹ ays (95% credible
interval [CrI]: 3.1, 4.9)â€
China, Vietnam, South Korea, Germany, Italy, Singapore, Hong Kong, Taiwan - 40
transmission pairsâ€‹ (â€‹ Ferreti et al. 2020)â€‹ - â€œâ€‹ we directly estimated the generation time
distribution from 40 source-recipient pairs...The distribution is best described by a
Weibull distribution with mean and median equal toâ€‹ 5.0 â€‹days and standard deviation of
1.9 daysâ€â€‹.

Caveatsâ€‹:
â— The serial interval is affected by policies of isolation and physical distancing. As such,
measurements from one place and time (e.g. Wuhan before lockdown) should not be applied
to another location (e.g. Lombardy after lockdown) without explicit explanation. As mentioned
for example in â€‹(Bi et al. 2020)â€‹: â€œâ€‹It should be noted this estimate includes the effect of isolation
on truncating the serial interval. Stratified results show that if the infector was isolated less than
3 days after infection the average serial interval was 3.6 days, increasing to 8.1 days if the
infector was isolated on the third day after symptom onset or laterâ€.
â— In general it is hard to track large networks of transmissions. Some sources use very small
numbers of infector-infectee pairs (e.g. < 10) to arrive at an estimate.
â— Possible biases in the selection of the pairs used for the analysis. In addition, recent contacts
are easier to remember than distant contacts leading to bias in the backward contact tracing,
toward shorter serial intervals.
â— Clusters of infections could make it difficult to determine which of several individuals is the
infectee.
â— The most common approach to estimate the serial or generation intervals is to use
contact-tracing data. In this approach infected individuals are questioned to identify their
infectors, and the duration between the infection times of infector and infectee is estimated.
This approach is inherently backward-looking, starting from infected individuals and going
back in time to identify their infectors. This backward-looking perspective biases the estimate
of the serial and generation intervals in the early stages of an epidemic, when cases grow
exponentially â€‹(Park et al. 2020)â€‹. Because the number of infected people grows exponentially,
infections with short generation or serial intervals will be overrepresented in the sampled
population, which will consequently lead to underestimating the generation and serial
intervals.

12

Comparison to other pathogensâ€‹:
â— No lockdown:
â—‹ SARS - (â€‹ Lipsitch et al. 2003) â€‹-â€‹ â€‹â€œThe mean serial interval in Singapore was â€‹8.4 d
â€‹ ays (SD =
3.8)â€
â—‹ MERS - â€‹(Cauchemez et al. 2016)â€‹ - â€‹â€œWe estimate that the serial interval (delay between
symptom onset in a case and symptom onset in the persons they infect) of MERS-CoV
has aâ€‹ m
â€‹ ean ofâ€‹ 6.8â€‹ (95% CI: 6.0, 7.8) daysâ€‹ â€‹and a SD of 4.1 (95% CI: 3.4, 5.0) days (Fig.
2C).â€
â—‹ Influenza -â€‹ (Cowling et al. 2009)â€‹ - â€‹â€œWe estimated the household serial interval of
influenza to beâ€‹ â€‹betweenâ€‹ 3 â€‹andâ€‹ 4 â€‹daysâ€â€‹.
â—‹ Tuberculosis - (â€‹ Ma et al. 2018)â€‹ - â€œâ€‹ the serial interval estimates from four studies were:
0.57, 1.42, 1.44 a
â€‹ ndâ€‹ 1.65â€‹ years;â€

13

Doubling time and exponential growth rate
Definitionâ€‹: The doubling time is the time it takes the cumulative number of cases to double.
Exponential growth rate is the slope of the curve of the log of infected cases versus time. The growth
rÏ„
ln2 = 2 ).
rate r and doubling time Ï„ are connected by the equation: r = ln2
Ï„ (as e = e
Best estimateâ€‹: situation specific (depends on location and interventions)
Methods of measurement and estimationâ€‹:
The exponential growth rate is usually estimated by an exponential fit to the curve of cumulative
infections.
Estimate:
â— Outbreak in Wuhan and mainland China:
â—‹ Estimates on the basis of the reported number of cases:
â–  (Muniz-Rodriguez et al. 2020a)â€‹ - â€œâ€‹ During January 20â€“February 9, the harmonic
mean of the arithmetic means of the doubling times estimated from cumulative
incidence ranged from â€‹1.4â€‹ (95% CI 1.2â€“2.0) days in Hunan Province toâ€‹ 3.1â€‹ (95%
CI 2.1â€“4.8) days in Xinjiang Province. We estimated doubling time as 2
â€‹ .5â€‹ (95% CI
2.4â€“2.6) days in Hubei Province. The cumulative incidence doubled 6 times in
Hubei Province during the study period. The harmonic mean of the arithmetic
means of doubling times for mainland China except Hubei Province wasâ€‹ 1.8
(95% CI 1.5â€“2.3) days. Fujian, Guangxi, Hebei, Heilongjiang, Henan, Hunan,
Jiangxi, Shandong, Sichuan, and Zhejiang provinces had a harmonic mean of the
arithmetic means of doubling times <2 days (Figure; Appendix Figure 1).â€
â–  (Li et al. 2020)â€‹ - â€â€‹ In the epidemic curve up to January 4, 2020, the epidemic
growth rate was 0.10 per dayâ€‹ (â€‹ 95% CI, 0.050 to 0.16) and the doubling time was
7.4 d
â€‹ aysâ€‹ â€‹(95% CI, 4.2 to 14).â€
â—‹ Estimates on the basis of the number of cases exported from Wuhan to cities outside
in mainland China and other countries:
â–  Ö·(Zhanwei Du et al. 2020) - â€œâ€‹ By fitting our epidemiologic model to data on the
first 19 cases reported outside of China, we estimate an epidemic doubling time
ofâ€‹ 7.31 â€‹daysâ€‹ â€‹(95% CrI 6.26â€“9.66 days) and a cumulative total of 12,400 (95% CrI
3,112â€“58,465) infections in Wuhan by January 22 (Appendix).â€
â–  (Wu et al. 2020a)â€‹ - â€‹â€œIn our baseline scenario, we estimated that Râ€‹0â€‹ was 2Â·68 (95%
CrI 2Â·47â€“2Â·86) with an epidemic doubling time ofâ€‹ 6.4 â€‹days (95% CrI 5Â·8â€“7Â·1;
figure 2). We estimated that 75815 individuals (95% CrI 37 304â€“130 330)
individuals had been infected in Greater Wuhan as of Jan 25, 2020.â€
â–  Ö·(Chinazzi et al. 2020) -â€‹ â€œHere we report the results for Tâ€‹gâ€‹ = 7.5 days (20). The
obtained posterior distribution provides an average Râ€‹0â€‹ = 2.57 [90% confidence
interval (CI): 2.37 to 2.78] and a doubling time of Td =â€‹ 4.2 â€‹days (90% CI: 3.8 to 4.7
days).â€
â–  (Q. Zhao, Chen, and Small 2020)â€‹ -â€‹ â€œAssuming the travel rate to the selected
countries and regions is constant over the study period, we found that the
epidemic was doubling in size every â€‹2.9 d
â€‹ aysâ€‹ (â€‹ 95% credible interval [CrI], 2
days--4.1 days). Using previously reported serial interval for 2019-nCoV, the
estimated basic reproduction number is 5.7 (95% CrI, 3.4--9.2)â€â€‹.

14

â– 

(Sanche et al. 2020)â€‹ - â€œâ€‹ By using 2 distinct approaches, we estimated the growth
rate of the early outbreak in Wuhan to be 0.21â€“0.30 per day (â€‹ â€‹a doubling time of
2.3â€“3.3 d
â€‹ ays)â€

Caveatsâ€‹:
â— If the fraction of cases that get detected changes over time, for example due to increased
testing, it can bias estimates. Various alternative data sources such as the number of deaths
can be used to compensate for varying ascertainment rates.
â— Studies make different assumptions about when exponential growth began (estimates range
from the end of November to 31th of December 2019), which leads to wide variation in
estimates of the growth rate and doubling time.
â— Our analysis (available â€‹hereâ€‹) suggests that mâ€‹ost of the wide variation in the exponential
growth rate, doubling times and reproduction number across studies of the Wuhan outbreak
stems from the choice of the start date. Large exponential growth rates (and short doubling
times) are mainly the result of assumptions regarding late initial time of exponential growth.
â— It is most difficult to estimate the magnitude of the outbreak in its early phases. The number
of reported cases is not necessarily reliable, as case count data can be confounded by low
surveillance intensity causing a deflation in the true number of cases.
â— In some cases inference was performed using international flight data and infected persons
reported outside of China. Because of the low numbers of people traveling abroad compared
with the total population size in Wuhan, this approach leads to substantial uncertainties.
Inferences based on a low number of observations are prone to measurement error when data
are incomplete or model assumptions are not fully justified. Furthermore, it was shown
(Niehus et al. 2020)â€‹ that in most countries there was underdetection of infected travellers
returning from Wuhan (by a factor of close to 3 on average, when compared to the
surveillance in Singapore).
â— (Q Zhao et al. 2020)â€‹ describes in detail how various elusive statistical biases can arise in
models that infer the epidemic progression, usually resulting in underestimations.
â— The growth rate is connected to the reproduction number via the generation interval. Similar
estimates for the growth rate may result in different reproduction numbers depending on
different assumptions regarding the generation interval and its distribution. See for example
(J. Wallinga and Lipsitch 2007)â€‹.

15

Basic reproduction number
Definition
The basic reproduction number of an infection, Râ€‹0â€‹, is the expected number of secondary infections
generated by an average infectious case in an entirely susceptible population.
This quantity determines the potential for an infectious agent to start an outbreak, the extent of
transmission in the absence of control measures, and the ability of control measures to reduce
spread. In contrast to Râ€‹0â€‹, the effective reproduction number, Râ€‹tâ€‹ (also denoted R(t) and Râ€‹eâ€‹), measures
the number of secondary cases generated by an infectious case once an epidemic is underway (see
the designated section for further details).
Best estimateâ€‹:â€‹ 2-6â€‹ (corresponding to doubling time of 2.5-7 days)
Methods of measurement and estimationâ€‹:
Râ€‹0â€‹ and Râ€‹tâ€‹ values are derived from fitting epidemiological models to data about the pandemic. These
data can include the number of reported cases, hospitalizations and deaths. Importantly, since Râ€‹0
values are the product of a fitting procedure, their values depend on both the model and the quality of
the underlying data. One approach to estimating Râ€‹0 is
based on fitting the cumulative number of
â€‹
cases during initial phases of the epidemic. To estimate Râ€‹0â€‹ this approach usually relies on the most
basic connection between Râ€‹0 and
the doubling time and growth rate (â€‹râ€‹). These two parameters are
â€‹
interrelated via the generation interval (see relevant section). For a characteristic value of the
generation interval g (units of days), with an exponential growth rate r (units of daysâ€‹-1â€‹) the connection
is given by R0 = erg . The epidemic grows by a factor of Râ€‹0â€‹ over each generation interval. In general,
the generation interval is characterized by a distribution g(t), where t is the time since infection, and
not a single value, and the connection to Râ€‹0â€‹ is expressed through the Lotka-Euler equation:
1
R0

=

âˆ

âˆ«

eâˆ’rt g(t)dt = M (âˆ’ r) . Here, M is the moment generating function of g(t), which has a familiar

t=0

form for commonly used distributions. For a generation interval with a normal distribution
2
1
R0 = erÎ¼âˆ’ 2(rÏƒ) where, Î¼, Ïƒ are the mean and standard deviation of the generation interval (â€‹ J. Wallinga
and Lipsitch 2007)â€‹. This is also a good approximation for generation intervals following a gamma
distribution.
Other approaches use a compartmental model to estimate Râ€‹0â€‹.â€‹ Here
Râ€‹0â€‹ is derived from the rates
â€‹
connecting the different compartments. For example, in an SIR (Susceptible-Infected-Removed)
Î²
model, R0 = Î³ where Î² is the effective contact rate, and ğ›¾ is the removal rate, equal to the inverse of
the period of infectiousness. For general compartment models (such as SEIR) Râ€‹0 is
given by the
â€‹
highest eigenvalue of the generation matrix (also known as the spectral radius).
Various sources estimate Râ€‹0â€‹ using the growth in the first stages of the outbreak and inference of the
relevant rates from comparison to the number of infected. Comparison to various proxy data
(exported cases, number of deaths) are used to validate and improve fits.
Estimatesâ€‹:
â— Outbreak in Wuhan and mainland China:
â—‹ Estimations on the basis of the number of cases exported from Wuhan to cities
outside in mainland China and other countries:

16

â– 

â– 
â– 

â– 

â– 

â– 

â—‹

(Wu et al. 2020a)â€‹ - SEIR model - â€‹â€œIn our baseline scenario, we estimated that R0
was â€‹2.68â€‹ (95% CrI 2.47â€“2.86) with an epidemic doubling time of 6Â·4 days (95%
CrI 5.8â€“7.1)â€â€‹. â€‹(assuming serial interval of 8.4, based on SARS)
(Read et al., 2020) -â€‹ S
â€‹ EIR model - â€œâ€‹ â€‹We calculated the basic reproductive number,
Râ€‹0â€‹, of the infection to be â€‹3.11â€‹ (95%CI, 2.39â€“4.13)â€‹â€
(Imai et al., n.d.)â€‹ - S
â€‹ tochastic simulations of outbreak trajectories - â€œâ€‹ â€‹We judge
that the most likely estimate corresponds to the smallest level of zoonotic
exposure explored here (40 cases), namely Râ€‹0â€‹=â€‹2.6â€‹ (Table 1 and Figure 1).
Uncertainty caused by the intrinsically random nature of epidemics and the
uncertainty in the level of zoonotic exposure gives a range of 1.5-3.5...Assuming
a shorter generation time (mean of 6.8 days rather than 8.4 days) reduces our
central estimate ofâ€‹ R
â€‹ 0â€‹â€‹ toâ€‹ 2.1 â€‹(uncertainty range: 1.3-2.7)â€‹â€
Ö·(Zhanwei Du et al. 2020) - SEIRâ€‹ - â€‹â€œBasic reproductive number, Râ€‹0â€‹: 1
â€‹ .90â€‹ (95% CrI
1.47â€“2.59â€‹)â€â€‹ (given in the appendix, they got epidemic doubling time of 7.3
days)
(Sanche et al. 2020)â€‹ - integration of high-resolution domestic travel data and
early infection data reported in provinces other than Hubei - â€œâ€‹ â€‹To include a wider
range of serial interval (i.e., 6â€“9 days) (Figure 5, panel A; Appendix 2 Figure 6),
given the uncertainties in these estimations, we estimated that the median of
estimated R isâ€‹ 5.7â€‹ (95% CI of 3.8â€“8.9) (Figure 5, panel B). The estimated R can
be lower if the serial interval is shorterâ€ â€‹ (They estimated that the exponential
growth rate of the outbreak is probably 0.21â€“0.3/day. Used high serial interval)
Ö·(Chinazzi
Ö·
et al. 2020) - â€‹â€œHere we report the results for Tg = 7.5 days (20). The
obtained posterior distribution provides an average Râ€‹0â€‹ = â€‹2.57â€‹ [90% confidence
interval (CI): 2.37 to 2.78] and a doubling time of Td = 4.2 days (90% CI: 3.8 to 4.7
days).â€

Estimations on the basis of the reported number of cases:
â–  (Shen et al. 2020)â€‹ - SEIJR model (SEIR + isolated compartment) â€œâ€‹ T
â€‹ he basic
reproduction number (Râ€‹0â€‹) of 2019-nCov, an indication of the initial
transmissibility of the virus, was estimated to be 4
â€‹ .71â€‹ (4.50-4.92) when the
epidemic started on 12th December 2019â€‹â€ â€‹ (used low rate of removal - inverse
of time to isolation = 6 days)
â–  (T. Liu et al. 2020)â€‹ - exponential growth rate -â€‹ â€‹â€œThe Râ€‹0â€‹ values of NCP were â€‹4.5
(95%CI: 4.4-4.6) and 4.4 (95%CI: 4.3-4.6) nationwide and in Wuhan, respectivelyâ€
(assuming serial interval with mean of 7.5 and SD of 3.4)
â–  (Riou and Althaus 2020)â€‹ - Stochastic simulations of outbreak trajectories - â€‹â€œâ€‹the
early human-to-human transmission of 2019-nCoV was characterised by values
of Râ€‹0â€‹ around â€‹2.2â€‹ (median value, with 90% high density interval: 1.4â€“3.8)â€
â–  (Li et al. 2020)â€‹ - exponential growth rate - â€œâ€‹ â€‹Using the serial interval distribution
above, we estimated that Râ€‹0â€‹ wasâ€‹ 2.2 (â€‹ 95% CI, 1.4 to 3.9)â€â€‹.â€‹(the shorter generation
time is closer to estimates of SARS-Cov2)
â–  (Tang et al. 2020)â€‹ - modified SEIR (including isolation) - â€‹â€œLikelihood-based
estimation of Râ€‹Câ€‹ during the outbreak in Wuhan gives a mean value of â€‹6.39â€‹ with
mean and variance of generation time of 6 and 2 days on the basis of a revised
data series (dataRev1). The reproduction number based on likelihood-based
estimation ranges from 1.66 to 10â€‹â€œâ€‹ (They assume exponential growth started at
1 Jan, resulting in a very high growth rate. Doubling time was about 2 days.
High number of parameters in their model)

17

(S. Zhao, Lin, et al. 2020)â€‹ - exponential growthâ€‹ â€œâ€‹ In Table 1, we estimated that the
Râ€‹0â€‹ ranges from 2
â€‹ .24 (â€‹ 95%CI: 1.96-2.55) to â€‹5.71â€‹ (95%CI: 4.24-7.54) associated
with an 8-fold to 0-fold increase in the reporting rateâ€
â–  (S. Zhao, Musa, et al. 2020)â€‹ - exponential growth with correction for
underreporting of cases - â€‹ â€œâ€‹ After accounting for the effect of under-reporting,
the Râ€‹0â€‹ was estimated atâ€‹ 2.56â€‹ (95% CI: 2.49â€“2.63), see Figure 1b, which is
consistent with many existing online preprints with range from 2 to 4 [5,20â€“22].â€
Beginning of Spreading in other countries:
â—‹ South Korea and Italy - â€‹(Zhuang et al. 2020)â€‹ -â€‹ â€œâ€‹We modelled the transmission process in
the Republic of Korea and Italy with a stochastic model, and estimated the basic
reproduction number Râ€‹0â€‹ asâ€‹ 2.6â€‹ (95% CI: 2.3â€“2.9) orâ€‹ 3.2â€‹ (95% CI: 2.9â€“3.5) in the Republic
of Korea, under the assumption that the exponential growth starting on 31 January or 5
February 2020, and â€‹2.6â€‹ (95% CI: 2.3â€“2.9)â€‹ â€‹orâ€‹ 3.3â€‹ (95% CI: 3.0â€“3.6) in Italy, under the
assumption that the exponential growth starting on 5 February or 10 February 2020,
respectivelyâ€â€‹ - assumed short serial interval distribution - gamma with mean 4.5 and
standard deviation of 3.1 days - might be good estimate for Korea due to their
aggressive policy, but not necessarily for the beginning of the epidemic in Italy.
â—‹ Iran - â€‹(Muniz-Rodriguez et al. 2020b)â€‹ - â€œâ€‹ To determine the transmission potential of
severe acute respiratory syndrome coronavirus 2 in Iran in 2020, we estimated the
reproduction number as â€‹4.4â€‹ (95% CI 3.9â€“4.9) by using a generalized growth model and
3.5â€‹ (95% CI 1.3â€“8.1) by using epidemic doubling time.â€â€‹ - assumed short serial interval
distribution: gamma with mean 4.5 and standard deviation of 3.1 days, despite no
aggressive interventions.
â– 

â—

Comparison to other pathogensâ€‹:
â— SARS - â€‹(Lipsitch et al. 2003)â€‹ -â€‹ â€‹â€œan approximate estimate of Râ€‹0â€‹ ranging from 2
â€‹ .2 â€‹toâ€‹ 3.6â€‹ for serial
intervals of 8 to 12 daysâ€
â— MERS - (â€‹ Majumder et al. 2014)â€‹ - â€œâ€‹ Iâ€‹ DEA model fits suggested a higher Râ€‹0â€‹ in Jeddahâ€‹ (3.5-6.7)
than in Riyadhâ€‹ (2.0-2.8)â€‹; control parameters suggested more rapid reduction in transmission in
the former city than the latterâ€.
â— Influenza -â€‹ (Biggerstaff et al. 2014)â€‹ - â€œâ€‹ The median R value for 1918 wasâ€‹ 1.80â€‹ (interquartile
range [IQR]: 1.47â€“2.27). Six studies reported seven 1957 pandemic R values. The median R
value for 1957 was 1
â€‹ .65â€‹ (IQR: 1.53â€“1.70). Four studies reported seven 1968 pandemic R values.
The median R value for 1968 was â€‹1.80â€‹ (IQR: 1.56â€“1.85). Fifty-seven studies reported 78 2009
pandemic R values. The median R value for 2009 was â€‹1.46â€‹ (IQR: 1.30â€“1.70) and was similar
across the two waves of illness: 1.46 for the first wave and 1.48 for the second wave.
Twenty-four studies reported 47 seasonal epidemic R values. The median R value for seasonal
influenza wasâ€‹ 1.28â€‹ (IQR:1.19â€“1.37)â€‹â€.
Caveatsâ€‹:
â— It is most difficult to estimate the magnitude of the outbreak in its early phases. The number
of reported cases is not necessarily a good source, as case count data can be confounded by
low surveillance intensity causing a deflation in the true number of cases. Another source for
inconsistency is incidents originated by contact with Wuhan seafood market rather than
contact with other infected individuals.

18

â—

â—
â—

â—

In some cases inference was performed by using international flight data and infected
persons reported outside of China. Because of the low numbers of persons traveling abroad
compared with the total population size in Wuhan, this approach leads to substantial
uncertainties. Inferences based on a low number of observations are prone to measurement
error when data are incomplete or model assumptions are not fully justified. Furthermore, it
was shown (â€‹ Niehus et al. 2020)â€‹ that in most countries there was underdetection of infected
travellers returning from Wuhan (by factor of close to 3 in average, when compared to the
surveillance in Singapore).
(Q Zhao et al. 2020)â€‹ describes in detail how various elusive statistical biases can arise in
models that infer the epidemic progression, usually resulting in underestimations.
The reproduction number is connected to the serial interval and growth rate. The early sources
didnâ€™t have reliable estimates for those, and thus are affected by the quality of their
assumptions.
Our analysis suggests that mâ€‹ost of the wide variation in the exponential growth rate and
reproduction number across studies of the Wuhan outbreak stems from the choice of the start
day. Large reproduction numbers are mainly due to assumptions regarding late initial time of
exponential growth.

19

Effective reproduction number
Definition
The effective reproduction number, Râ€‹t (also
denoted by R(t), R and Râ€‹eâ€‹) is the number of secondary
â€‹
cases generated by an infectious case at a given moment (t) once an epidemic is underway. Unlike
the basic reproductive number, Râ€‹tâ€‹ is time and situation specific, used to characterize pathogen
transmissibility during an epidemic, and enabling assessment of the effectiveness of interventions.
We should also emphasize the distinction between the 'physical' versus 'operational' meaning of Râ€‹tâ€‹:
the 'physicalâ€™ meaning of the number of infections an infectious person makes on average (as defined
above) does not depend on the generation interval. However, the operational definition which is
inferred from models fitted to the number of cases or derived from logarithmic slope of infection
curves depends on serial interval.
Best estimateâ€‹: situation specific (depends on location and interventions)
Methods of measurement and estimationâ€‹:
Like the basic reproduction number, Râ€‹tâ€‹ values may be derived from fitting epidemiological
compartmental models to data about the pandemic. These data can include the number of reported
cases, hospitalizations and deaths. The two basic types of models are compartment-based models,
such as SIR and SEIR, and renewal-equation models (see details below).
Estimation of effective Râ€‹tâ€‹ via compartment models is similar to the estimation of Râ€‹0â€‹, and it makes use
of the assumptions built into the model, such as: the different compartments and the distribution of
time in each compartment. In order to estimate the effects of different interventions, such
epidemiological models are also used to predict the Râ€‹tâ€‹ based on assumptions and observed
epidemiological parameters. Other approaches for estimation of the effective reproduction number
use only the serial/generation interval via the renewal function, like those of (â€‹ Cori et al. 2013; Jacco
Wallinga and Teunis 2004)â€‹. Renewal-equation estimates themselves can be divided into two basic
methods, which differ by the inference method, as well as the use of right censored data:
â— The first method â€‹(Jacco Wallinga and Teunis 2004)â€‹ makes use of both past and future daily
cases respective to the time step at which Râ€‹tâ€‹ is inferred. Thus, it estimates the average
number of secondary cases that a case infected at time step t eventually infected, estimated
in retrospect. This method is also referred to as the â€œcase reproduction numberâ€.
â— The second method (â€‹ Cori et al. 2013; Thompson et al. 2019)â€‹ only uses past daily cases.
Hence, the method estimates the average number of secondary cases that each infected
individual would infect if the conditions remained as they were at time t. This method is also
referred to as â€œthe instantaneous reproduction numberâ€.
Estimatesâ€‹:
â— Intensive interventions : isolation of patients with symptoms, contact tracing, physical
distancing, including restriction (or advising against) of large social gatherings in order to
mitigate the risk of community transmission:
â—‹ Singapore (â€‹ Tariq et al. 2020)â€‹ - characterized daily incidence of local cases using the
generalized logistic growth model (GLM) after adjusting for imported cases: â€‹â€œT
â€‹ he
effective reproduction number peaked with a mean value â€‹~1.0â€‹ between February 6-12,
2020 and declined thereafter. As of March 5, 2020, our most recent estimate of Râ€‹tâ€‹ is at
0.9 (â€‹ 95% CI: 0.7,1.0)â€‹â€

20

South Korea (â€‹ Shim et al. 2020)â€‹ - generalized growth model: â€‹â€œ.â€‹ .. the intrinsic growth rate
(r) was estimated at 0.6 (95% CI: 0.6, 0.7) and the scaling of growth parameter (p) was
estimated at 0.8 (95% CI: 0.7, 0.8), indicating sub-exponential growth dynamics of
COVID-19 in Korea (Figure 2, Table 3). The mean reproduction number Râ€‹tâ€‹ was estimated
atâ€‹ 1.5â€‹ (95% CI: 1.4, 1.6) as of Feb 26 2020â€‹.â€
â—‹ Hong Kong â€‹(Cowling et al. 2020)â€‹ - Using the method by â€‹(Thompson et al. 2019)â€‹,
improved version of the approach of â€‹(Cori et al. 2013)â€‹ â€œâ€‹Although unlinked COVID-19
cases have been detected in increasing numbers since early March, transmissibility (Râ€‹tâ€‹ )
remains around the critical threshold ofâ€‹ 1â€‹ (figure 2)â€
â—‹ Sweden - no lock down â€‹(Folkhalsomyndigheten 2020)â€‹ - â€‹using SEIR methodâ€‹ -â€‹ â€œBased on
reported cases during the period 17 February to 10 April, we calculated the value of the
reproduction number at a certain time, ğ‘…â€‹ğ‘’(â€‹ ğ‘¡). In all three scenarios, ğ‘…â€‹eâ€‹(ğ‘¡) takes a value jâ€‹ ust
above or just below oneâ€‹ on 10 April. See Table 3 for reproductions numbers with 95%
confidence interval.â€
Interventions in Wuhan - before and after lockdown
â—‹ (Lipsitch M, Keya J, Cobey S.E. 2020)â€‹ following (â€‹ Pan et al. 2020)â€‹ - using (â€‹ Jacco
Wallinga and Teunis 2004)â€‹ method during the period of local lockdown (period 3) Râ€‹t
dropped below 1 and reached 0.3 by the end of March -â€‹ â€‹â€œtaking into account the evident
decline of the epidemic curve that began during Period 3, finds that Râ€‹tâ€‹ dropped below 1
during Period 3, specifically on 28-29 Jan. (Fig. 1)â€‹â€
â—‹ (C. Wang et al. 2020)â€‹ - extended SEIR model to account for population movement,
unascertained cases, and quarantine by hospitalization -â€‹ â€œThe effective reproductive
number dropped from â€‹3.86â€‹ (95% credible interval 3.74 to 3.97) before interventions to
0.32â€‹ (0.28 to 0.37)â€‹ â€‹post interventionsâ€
Interventions in other countries - before and after lockdown
â—‹ France (â€‹ Salje et al. 2020)â€‹ - deterministic compartmental model stratified by age - from
figure 4, Râ€‹0â€‹=3.3 and Râ€‹lockdownâ€‹=0.5
â—‹ 11 European countries â€‹(Flaxman et al., 2020)â€‹ - semi-mechanistic Bayesian hierarchical
modelâ€‹ attempts to infer the impact of the various interventions (assuming each has
the same relative effect on R, independent of the country). Based on reported death
cases - â€œâ€‹ We estimate large changes in ğ‘…â€‹ğ‘¡â€‹ in response to the combined
non-pharmaceutical interventions. Our results, which are driven largely by countries with
advanced epidemics and larger numbers of deaths (e.g. Italy, Spain), suggest that these
interventions have together had a substantial impact on transmission, as measured by
changes in the estimated reproduction number Râ€‹tâ€‹. Across all countries we find current
estimates of Râ€‹tâ€‹ to range from a posterior mean ofâ€‹ 0.97â€‹ [0.14-2.14] for Norway to a
posterior mean ofâ€‹ 2.64 [â€‹ 1.40-4.18] for Sweden, with an average ofâ€‹ 1.43 a
â€‹ cross the 11
country posterior means, a 64% reduction compared to the pre-intervention valuesâ€
â—‹

â—

â—

Caveatsâ€‹:
â— Various interventions such as isolation of symptomatic patients and contact tracing affect
both the average number of secondary cases generated by an infected individual as well the
serial interval itself.Usually the models assume a constant serial interval and consider only

21

â—

â—

possible changes in Râ€‹tâ€‹. Thus the models infer the â€˜operationalâ€™ Râ€‹t that
correspond to a constant
â€‹
serial interval.
Similar to the basic reproduction number, the effective reproduction number also depends on
the quality of the data regarding the number of cases taken as is from formal reports, or
estimated based on proxies such as traveling data.
Other caveats relevant to the basic reproduction number are also relevant to the time specific
statistics:
â—‹ It is most difficult to estimate the magnitude of the outbreak in its early phases. The
number of reported cases is not necessarily a good source, as case count data can be
confounded by reservoir spillover events, stochasticity in the initial phase of the
outbreak, and low surveillance intensity.
â—‹ inference was performed by using international flight data and infected persons
reported outside of China. Because of the low numbers of persons traveling abroad
compared with the total population size in Wuhan, this approach leads to substantial
uncertainties . Inferences based on a low number of observations are prone to
measurement error when data are incomplete or model assumptions are not fully
justified. Furthermore, it was shown (â€‹ Niehus et al. 2020)â€‹ that in most countries there
was underdetection of infected travellers returning from Wuhan.

Comparison to other pathogensâ€‹:
â— SARS â—‹ (Wallinga and Teunis 2004)â€‹ - â€â€‹ During the early phase of the SARS epidemic... Each case
produced approximately three secondary infections (table 1). A value of R slightly higher
than 3
â€‹ â€‹â€¦ Around mid-March, control measures were implemented in all regions, and
during this period the effective reproduction numbers decreased sharplyâ€¦ After the first
World Health Organization global alert, each case producedâ€‹ a
â€‹ pproximatelyâ€‹ 0.7
secondary infectionsâ€
â—‹ (Cori et al. 2013)â€‹ - â€œâ€‹ For the SARS outbreak in Hong Kong in 2003, we find 2 successive
peaks in R. The first occurred in the middle of week 3 with a median estimate of 1
â€‹ 2.2
(95% CI: 10.0â€“14.7), and the second occurred at the end of week 6 with a median
estimate of â€‹2.6â€‹ (95% CI: 2.4â€“2.9). R then fell below 1 by the end of week 7.â€
â— MERS -â€‹ â€‹(Thompson et al. 2019)â€‹ - fâ€‹ ig 5: Râ€‹tâ€‹ fluctuated between 10/14 to 1/16 between maximal
value of less than 2.5, minimal value of about 0.5.
â— Influenza - (â€‹ Thompson et al. 2019)â€‹ â€The median reproduction number estimate for the first
seven days of the outbreak (April 18thâ€“April 24th 2009) wasâ€‹ 3.3â€‹ â€“ with 95% credible interval
(95% CrI) given by (2.1,5.6) â€“ and the mean estimate for this period was 3.4â€â€‹.
â— Ebola â—‹ (Althaus 2015)â€‹ - using SEIR model - â€‹ â€‹â€œI fitted an EVD transmission model to previously
published data of this outbreak and estimated the basic reproduction number Râ€‹0â€‹ = 5.2
(95% CI [4.0â€“6.7]). The model suggests that the net reproduction number Râ€‹tâ€‹ fellâ€‹ below
unity 2
â€‹ 8 days (95% CI [25â€“34] days) after the onset of symptoms in the index caseâ€.â€‹ See
figure 2 for details.
â—‹ (Thompson et al. 2019)â€‹ -â€‹ fig 4: estimates for Râ€‹tâ€‹ in Liberia depend on the assumption of
serial interval distributionâ€™s shape.

22

Online tools to estimate the effective reproduction number in various locations
â— https://mrc-ide.github.io/covid19-short-term-forecasts/#individual-model-outputs
â— https://covid19-projections.com/infections-tracker/
â— http://rt.live/
â— https://mrc-ide.github.io/covid19estimates/#/
(â€‹https://github.com/ImperialCollegeLondon/covid19modelâ€‹)
â— http://trackingr-env.eba-9muars8y.us-east-2.elasticbeanstalk.com/
â— https://covidactnow.org/

23

Dispersion of the secondary infection distribution

Definition
The â€œoffspring distributionâ€ of an epidemic is the distribution of the number of secondary cases due
to each primary infection. The mean of this distribution is Râ€‹tâ€‹ by definition, though Râ€‹tâ€‹ values derived
from fits might differ from this true Râ€‹tâ€‹ value due to incorrect assumptions or issues associated with
the fitting process. The offspring distribution is generally considered to adopt a negative binomial
distribution which is characterized by a mean (Râ€‹tâ€‹) and a dispersion parameter k, such that the
variance is given by Râ€‹tâ€‹(1+Râ€‹tâ€‹/k). The negative binomial distribution is generally used instead of
Poisson to allow for unequal mean and variance. Smaller values of k indicate greater heterogeneity.
In general k<<1 is associated with a high number of â€˜superspreadersâ€™ - individuals that infect much
more than the average Râ€‹0.â€‹ Values of k>1 are associated with a low number of â€˜superspreadersâ€™, as the
number of secondary cases of each primary infection is relatively even.
The formula for the probability density p of the number of secondary infections n, is given by:
n
Î“(n+k)
k k Rt
p(n) = n! Î“(k) ( k+R
) ( k+R ) where Râ€‹tâ€‹ is the mean number of secondary cases, k is the dispersion of the
t

t

secondary infection distribution, and ğ›¤ denote the gamma function. The limits of this distribution are
the Poisson distribution, when kâ†’âˆ and the geometric distribution when k=1.
Best estimateâ€‹:
No interventions: 0
â€‹ .1-0.2
Interventions (physical distancing, contact tracing, lockdowns) : â€‹0.4-1
Methods of measurement and estimationâ€‹:
Estimation is made based on a chain transmission model, in which each infected person transmits
the infection to a number of subjects sampled randomly from a distribution with mean Râ€‹tâ€‹ and
dispersion k. Usually, the model is compared to data regarding the size of different clusters (for
different countries, for example) with an initial number of spreaders (for example, known imported
cases).
Other methods use empirical data regarding the number of secondary cases in a defined cluster with
good documentation. They fit the transmission data to a negative binomial distribution to extract an
estimate for the dispersion parameter. A version of this method, proposed by (â€‹ Lloyd-Smith et al.
2005)â€‹ makes use of only the average number of secondary cases and the proportion of cases with no
secondary transmission by numerically solving an equation that connects the probability of
no-transmission with the dispersion.
Estimatesâ€‹:
â—

â—

Early outbreak:
â—‹ Early spreading in Wuhan - (â€‹ Riou and Althaus 2020)â€‹ - â€œâ€‹ â€‹The observed data at this point
are compatible with aâ€‹ lâ€‹arge range of values for the dispersion parameter k (median:
0.54, 90% high density interval: 0.014â€“6.95). However, our simulations suggest that very
low values of k are less likely.â€
â—‹ Early spreading in several countries - â€‹(Endo et al. 2020)â€‹ -â€‹ â€œThe result of the joint
estimation suggested the likely bounds for Râ€‹0â€‹ and k (95% CrIs: Râ€‹0â€‹ 1.4â€“12;â€‹ kâ€‹ â€‹ 0.04â€“0.2â€‹)â€â€‹ .â€‹
Containment effort - physical distancing and contact tracing:

24

China, Shenzhen - (â€‹ Bi et al. 2020)â€‹ - contact tracing - â€œâ€‹ â€‹The mean number of secondary
cases caused by each index case (i.e., the observed reproductive number, R), was 0.4
(95% CI 0.3,0.5). The distribution of personal reproductive numbers was highly
overdispersed, with 80% of infections being caused by 8.9% (95% CI 3.5,10.8) of cases
(negative binomial dispersion parameterâ€‹ 0.58,â€‹ 95% CI 0.35, 1.18)â€‹.â€
â—‹ Hong Kong under strong containment - â€‹(Adam et al. 2020)â€‹- â€œâ€‹ â€‹From the empirical
offspring distribution and fitted negative binomial distribution shown in Figure 2B, we
estimated an observed reproductive number (R) of 0.58 (95% CI: 0.45 â€“ 0.71) and
dispersion parameter (k) ofâ€‹ 0.45â€‹ (95% CI: 0.31 â€“ 0.76). Given a superspreading of 6-8
secondary cases, we directly observed 2-4 SSEs where the source was known.
Likelihood analysis based on final cluster sizes increased the estimate of R to 0.75 (95%
CI: 0.6 â€“ 0.96) and decreased estimates of k toâ€‹ 0.37â€‹ (95% CI: 0.16 â€“ 1.16). Based on
these estimates we determined a coefficient of variation of 2.5 and inferred that
approximately 20% of SARS-CoV-2 infections are responsible for 80% of all transmission
events in Hong Kongâ€
â—‹ Singapore under strong containment - (â€‹ Tariq et al. 2020)â€‹ -â€‹ â€‹ â€‹â€œâ€‹The dispersion parameter is
estimated atâ€‹ 0.4â€‹ (95% CI: 0.1, Inf.) indicating higher transmission heterogeneityâ€
Tianjin, China before and after containment efforts - (â€‹ Y Zhang et al. 2020)â€‹ - â€œâ€‹we estimated the
reproductive number R and the dispersion parameter k (lower value indicating higher
heterogeneity) to be 0.67 (95% CI: 0.54â€“0.84) and 0
â€‹ .25â€‹ (95% CI: 0.13â€“0.88), respectivelyâ€â€‹. They
also give results for before (k=0.14) and after government control measures (k=0.77)
China outside of Hubei Province under travel lockdown - â€‹(D. He et al. 2020), (â€‹ Xu et al. 2020)â€‹ â€œwe obtained raw data of number of secondary cases from a study by Xu et al [4], where k can
be readily calculated asâ€‹ 0.8 â€‹(95%CI 0.63, 0.98).â€
Diamond princess cruise ship -â€‹ (S. Zhao, Cao, et al. 2020)â€‹ -â€‹ â€‹â€œWe estimate theâ€‹ â€‹dispersion term
(k) to beâ€‹ 44â€‹ (95%CI: 6âˆ’88), which is significantly larger than 1 and consistent with [7]. The
simulation results with or without dispersion term (k) were largely consistent, which suggests
absence of superspreading events (note that low k implies high chance of superspreading
events)â€â€‹. Because this is only anecdotal evidence from a non-representative setting, we do not
include it in our best estimate
â—‹

â—

â—

â—

Caveatsâ€‹:
â— Some of the analysis relies on the overall size of clusters and their initial number of spreaders.
However, in an emerging disease it is hard to assess the total size of the cluster as it depends
on the fraction of the population being tested (and the testing policy). In addition, the initial
number of (imported) cases may be influenced by misdetection of a few cases.
â— It is not always clear from case reports which cases are epidemiologically linked. Hence, the
extent and precision of the epidemiological investigation could also affect the assessment of
cluster sizes and the proportion of cases with no secondary infections.
â— Many of the interventions meant to control the spreading, like isolation of symptomatic
patients and contact tracing, affect the dispersion, as they aim to prevent events of large
spreading (as well as the mean = Râ€‹0â€‹). Thus, it is important to divide the data according to the
level of intervention
Comparison to other pathogensâ€‹:
â— (Lloyd-Smith et al. 2005)â€‹ - analyzed previous directly transmitted infections (Fig. 1b, c and
Supplementary Tables 1, 2):

25

â—
â—

SARS - 0
â€‹ .16 â€‹(90%CI 0.11-0.64)
Measles (US 1997-1999) - 0
â€‹ .23â€‹ (0.16-0.39)
Smallpox (Europe, Benin, Pakistan) - â€‹0.32-0.72
MERS - (â€‹ Kucharski and Althaus 2015)â€‹ - â€œâ€‹ Our estimate for MERS-CoV is similar, withâ€‹ â€‹k = 0
â€‹ .26
(90% CI: 0.11â€“ 0.87, 95% CI: 0.09â€“1.24)â€â€‹.
Influenza (1918 Pandemic) - â€‹(Fraser et al. 2011)â€‹ - â€‹0.94 (â€‹ 0.59-1.72) (taken from table 1)

26

Fraction of asymptomatic infections
Definitionâ€‹: The fraction of infected people not showing noticeable symptoms throughout their
infection. Note, this is different from pre-symptomatic patients, who carry the virus but will only show
symptoms later (once their incubation period has passed).
Best estimateâ€‹: 2
â€‹ 0-70%, a population-wide average, with strong age dependence such that estimates
depend on demographics.
Methods of measurement and estimationâ€‹:
There are three main methods for estimating the fraction of asymptomatic infections. The first
method randomly samples the population to identify the subset of infected individuals, and then
follows-up on those cases to see if they develop symptoms.
The second relies on contact tracing of index cases in specific clusters, identification of the infected
contacts of the index cases and monitoring of their symptoms. This type of measurement is not a
fully random sample and might exhibit some biases in the sampled population. We refer to this type
of measurement as â€œsemi-randomâ€.
The third method relies on epidemiological compartment models. In these models, the fraction of
asymptomatic cases can be represented by a unique compartment separate from the symptomatic
cases. The fraction of asymptomatic cases is one parameter in this model, which could be fitted, i.e.
inferred, along with the other parameters of the model, to time course data of the epidemic.
Estimatesâ€‹:
â— Random sample
â—‹ Iceland - 1221 cases (â€‹Gudbjartsson et al. 2020â€‹) - â€œâ€‹Notably, â€‹43%â€‹ of the participants who
tested positive reported having no symptoms, although symptoms almost certainly
developed later in some of themâ€‹â€
â—‹ Vo, Italy - 81 cases - (â€‹Lavezzo et al. 2020â€‹) - â€œâ€‹Notably, â€‹43.2% (â€‹ 95% CI 32.2-54.7%) of the
confirmed SARS CoV-2 infections detected across the two surveys were asymptomaticâ€‹â€
â—‹ Tibetan Autonomous Prefecture - 83 cases - (â€‹ Song et al. 2020)â€‹ - â€œâ€‹18 (18/83, â€‹21.7â€‹%)
individuals were identified as asymptomatic carriers, with a predominant distribution of
males (61.0%) (Table 1). The median age was 31 years and one third of the
asymptomatic individuals were students, aged under 20 yearsâ€‹â€.
â—‹ Spain - about 3000 seropositive cases - â€‹(Pâ€‹ollÃ¡nâ€‹ et al. 2020)â€‹ - â€œâ€‹Around a third of
seropositive participants were asymptomatic, ranging from â€‹21.9% (â€‹ 19.1â€“24.9) toâ€‹ 35.8%
(33.1â€“38.5).â€‹â€
â— Contact tracing (semi-random)
â—‹ Korea, call center - 97 cases - â€‹(Park et al. 2020)â€‹ - â€œâ€‹The role of asymptomatic COVID-19
case-patients in spreading the disease is of great concern. Among 97 confirmed
COVID-19 case-patients in this study, 4â€‹ (4.1%)â€‹ remained asymptomatic during the
14-days of monitoringâ€‹â€ (72%) were women; mean age was 38 years (range 20â€“80
years)
â—‹ Shenzhen, China - 391 cases - â€‹(Bi et al. 2020)â€‹ â€œâ€‹Further, in this group, â€‹20% w
â€‹ ere
asymptomaticâ€‹ a
â€‹ t the time of first clinical assessment and nearly 30% did not have
feverâ€‹â€.
â—‹ Brunei - 71 cases - (â€‹ Chaw et al. 2020)â€‹ - â€œâ€‹A substantial proportion of cases were
presymptomatic (31.0%, n=22) or asymptomatic (â€‹12.7%â€‹, n = 9)â€‹â€

27

â—‹

â—‹

â—‹

â—

Lombardy, Italy - 2351 close contacts of index cases - (â€‹ Poletti et al. 2020)â€‹ - â€œâ€‹ Of the
2,351 confirmed SARS-CoV-2 infections, 849 (36.1%) were symptomatic.â€,â€‹ i.e. 6
â€‹ 3.9â€‹%
asymptomatic,â€‹ â€œData stratified by sex, age and testing procedure are displayed in Table
1.â€
Taiwan - 100 cases - â€‹(Cheng et al. 2020)â€‹ - â€œâ€‹As of March 18, 2020, there were 100
patients with laboratory-confirmed COVID-19 in Taiwan, including 10 clusters of patients
and 9 asymptomatic patients.â€‹â€ i.e. the fraction of asymptomatic cases is â€‹9%
Guangzhou, China - 129 cases - (â€‹ Luo et al. 2020)â€‹ - â€œâ€‹During quarantine period, 129 cases
(2.6%) were diagnosed, with 8 asymptomatic (â€‹6.2%â€‹), 49 mild (38.0%), and 5 (3.9%)
severe to critical casesâ€‹â€

Epidemiological models
â—‹ Wuhan - (â€‹ Davies et al. 2020)â€‹ - â€œâ€‹The age-dependent clinical proportion was markedly
lower in younger age groups in all regions (Fig 2b), with 20% of infections in children
under 10 resulting in clinical cases, rising to over 70% in adults over 70 in the consensus
age distribution estimated across all regions.â€â€‹ Thus, 80% asymptomatic cases in
children under 10 and 30% in adults over 70. A simple average over the averages of the
age groups in Table 3 yields an average of â€‹57%â€‹. Non clinical cases include
asymptomatic as well as mild cases, not reported or documented.

Caveatsâ€‹:
â— Reporting of mild symptoms is subjective and so the dividing line between pre-symptomatic
and asymptomatic cases is not well-defined.
â— While in some cases, a large collection of samples were taken, it is very challenging to take a
truly random sample of a large population. Many studies report the asymptomatic fraction for
a highly idiosyncratic study population that certainly differs greatly from the general
population, for example the passengers of the Diamond Princess cruise ship..
â— To estimate the true fraction of asymptomatic cases, researchers need to follow-up on cases
which did not show symptoms at the time of testing to verify that these are truly
asymptomatic and not presymptomatic cases.
â— Even though there is evidence that asymptomatic cases have viral loads similar to those of
symptomatic cases â€‹(Zou et al. 2020)â€‹, there are, on the other hand, also reports of a
connection between the severity of symptoms and viral load â€‹(Liu et al. 2020)â€‹. Thus there are
contradictory reports on the relationship between symptom severity and the viral load, so it is
unclear if asymptomatic cases would be harder to detect in random surveys. If asymptomatic
cases indeed go undetected, this will cause an underestimation of their true fraction.
â— When performing random population testing, the false positive and false negative rates of the
test need to be accounted for in order to accurately project the associated uncertainty of the
estimates based on the tests. This may lead to significant over-estimation of asymptomatic
cases in screening tests, where the disease prevalence is very low.
â— A recent review (â€‹ Oran and Topol 2020)â€‹ states in its abstract, based on data largely overlapping
with the sources provided above, that a range of 40%-45% of infections are asymptomatic.
Such a narrow confidence range is hard to support given the large variation in the fraction of
asymptomatic infections between studies, as well as other possible biases and caveats
described above. In the discussion it is stated less conclusively: â€œâ€‹ On the basis of the 3 cohorts
with representative samplesâ€”Iceland and Indiana, with data gathered through random selection
of participants, and Vo', with data for nearly all residentsâ€”the asymptomatic infection rate may

28

â—

be as high as 40% to 45%. A conservative estimate would be 30% or higher to account for the
presymptomatic admixture that has thus far not been adequately quantified"
It is important to make the distinction between the fraction of asymptomatic cases and the
fraction of undiagnosed, undetected or unreported cases. In seroprevalence studies, the
actual fraction of infected cases is much higher (many times more than 10-fold) than the
number of reported cases (see the IFR section for examples of such seroprevalence studies).
This does not mean that all these extra cases are all asymptomatic. Even when an infected
person shows symptoms, there is still a large probability that their infection will not be tested
or reported, for different reasons (symptoms might not be significant enough to make the
infected person seek medical help, limitations on the testing capacity, etc.).

Lower quality data
â—

â—

Small sample sizes:
â—‹ Japanese citizens evacuated from Wuhan, China - 13 cases - (â€‹Nishiura et al. 2020â€‹)â€œUsing a binomial distribution, the asymptomatic ratio is thus estimated at 3
â€‹ 0.8%â€‹ (95%
confidence interval (CI): 7.7%, 53.8%)â€â€‹ (sample size was very small).
â—‹ Korea - 28 cases (â€‹ Ki et al. 2020)â€‹ - â€œâ€‹ Of the 28 infected patients diagnosed in Korea, 3
were asymptomaticâ€
â—‹ Hubei - 23 cases â€‹(Long et al. 2020)â€‹ - â€‹â€œA total of 16 out of 164 cases were confirmed by
RT-PCR during Jan 31 to Feb 9, 2020, with 3 cases reporting no symptoms. The other
148 cases were no symptoms and negative in RT-PCR tests. On March 1, 2020, serum
samples were collected from these 164 cases for antibody tests. The 16 RT-PCR
confirmed cases were positive in IgG or/and IgM. Strikingly, 7 of the 148 cases who
were excluded previously by negative nucleic acid results also showed positive results in
IgG or/and IgM, indicating that 4.3% (7/162) of close contacts were missed by nucleic
acid test. In addition, about 6.1% (10/164) of this cohort were asymptomatic infection.â€â€‹ There were 10 asymptomatic cases among a total of 23 cases identified, implying 4
â€‹ 3%
are asymptomatic.
â—‹ Vietnam - 30 cases â€‹(Chau et al. 2020)â€‹ - â€œâ€‹Of these, 30 participated in the study: 13(â€‹43%â€‹)
never had symptoms and 17(57%) were symptomaticâ€‹â€
â—‹ Liaocheng, Chine - 24 cases (â€‹ Tian et al. 2020)â€‹ - Table 1â€œâ€‹Asymptomatic (%) 7/24
(â€‹29.17â€‹)â€‹â€
Non representative sample:
â—‹ USA, Nursing home in Washington - â€‹(Arons et al. 2020)â€‹ - â€‹6%â€‹ (3/48) â€œâ€‹ Of the 48 residents
who tested positive from the surveys, 17 (35%) reported typical symptoms, 4 (8%)
reported only atypical symptoms, and 27 (56%) reported no new symptoms or changes
in chronic symptoms at the time of testingâ€¦ In the 7 days after their positive test, 24 of
the 27 asymptomatic residents (89%) had onset of symptoms and were recategorized
as presymptomaticâ€â€‹ - mean age of 76, 98% with coexisting conditions.
â—‹ Diamond Princess cruise ship - (â€‹Mizumoto et al. 2020â€‹) - delay adjusted - â€‹â€œThe
estimated asymptomatic proportion was â€‹17.9%â€‹ (95% credible interval (CrI):
15.5â€“20.2%)â€ â€‹- older population.
â—‹ Children in China (â€‹Dong et alâ€‹) - â€‹â€œFor the severity of patients (including both confirmed
and suspected cases), 94 (â€‹4.4 %â€‹), 1091 (50.9 %) and 831 (38.8 %) patients were
diagnosed as asymptomatic, mild or moderate cases, respectively, totally accounted for
94.1 % of all cases.â€â€‹ - Only children, not clear if suspected cases are indeed cases.

29

â—‹

â—‹

â—‹

Repatriation flights to Greece 40 cases - (â€‹Lytras et al. 2020â€‹) - Table 1. 35
asymptomatic cases out of 40 positive cases or 8
â€‹ 7.5%.â€‹ â€œâ€‹The passengersâ€™ median age
was 27 years (interquartile range 22â€“40 years)â€.
Pregnant women admitted for delivery (â€‹ Sutton et al. 2020)â€‹ - â€‹â€œThus, 29 of the 33 patients
who were positive for SARS-CoV-2 at admission (â€‹87.9%â€‹) had no symptoms of Covid-19
at presentation.â€
Homeless shelter in Boston, USA â€‹(Baggett et al. 2020)â€‹ - â€‹â€œA total of 147 participants
(36.0%) had PCR test results positive for SARS-CoV-2. Men constituted 84.4% of
individuals with PCR-positive results and 64.4% of individuals with PCR-negative results.
Among individuals with PCR test results positive for SARS-CoV-2, cough (7.5%),
shortness of breath (1.4%), and fever (0.7%) were all uncommon, and 8
â€‹ 7.8%â€‹ were
asymptomatic.â€

30

Household secondary attack rate
Definitionâ€‹: The fraction of the infecteeâ€™s household members that they infect on average.
Best estimateâ€‹: 5
â€‹ -30%
Methods of measurement and estimationâ€‹: The secondary attack rate is usually estimated based on
contact tracing data. By identifying the primary infected individual in the household, other household
members are tested and secondary infections are identified. The secondary attack rate is calculated
as the fraction of the household members of an infected individual who end up infected with the
virus.
Estimatesâ€‹:
â— (Bi et al. 2020)â€‹ - â€œâ€‹The household secondary attack rate was â€‹11Â·2%â€‹ (95% CI 9Â·1â€“13Â·8), and
children were as likely to be infected as adults.â€‹â€
â— (Jing et al. 2020)â€‹ - â€œâ€‹We estimated the household SAR to be â€‹13.8%â€‹ (95% CI: 11.1-17.0%) if
household contacts are defined as all close relatives and 1
â€‹ 9.3%â€‹ (95% CI: 15.5-23.9%) if
household contacts only include those at the same residential address as the casesâ€‹â€
â— (Wang et al. 2020)â€‹ - â€œâ€‹The rate of secondary transmission among household contacts of patients
with SARS-CoV-2 infection was 3
â€‹ 0%â€‹â€
â— (Park et al. 2020)â€‹ - â€œâ€‹The household secondary attack rate among symptomatic case-patients
was â€‹16.2%â€‹ (95% CI 11.6%â€“ 22.0%)â€‹â€
â— (WHO 2020)â€‹ - â€œâ€‹Household transmission studies are currently underway, but preliminary studies
ongoing in Guangdong estimate the secondary attack rate in households ranges from 3
â€‹ -10%â€‹â€
â— (Korean CDC 2020)â€‹ - â€œâ€‹There were 119 household contacts, of which 9 individuals developed
COVID-19 resulting in a secondary attack rate of â€‹7.56%â€‹ (95% CI 3.7â€“14.26)â€‹â€
â— (Burke et al. 2020)â€‹ - â€œâ€‹and a symptomatic secondary attack rate of â€‹10.5%â€‹ (95% CI = 2.9%â€“31.4%)
among household members.â€‹â€
â— (Cheng et al. 2020)â€‹ - â€œâ€‹The attack rate was higher among household (â€‹4.6%â€‹ [95% CI, 2.3%-9.3%])
and nonhousehold (5.3% [95% CI, 2.1%-12.8%]) family contacts than that in health care or other
settingsâ€‹â€
â— (Luo et al. 2020)â€‹ - â€œâ€‹Among different modes of contact, 53 household contacts were the most
dangerous in catching with infection of 54 COVID-19, with an incidence of 1
â€‹ 0.2%.â€‹â€
â— (Chen et al. 2020)â€‹ - â€œâ€‹Living with the case (â€‹ 13.26%)â€‹, taking the same transportation (11.91%),
dinner and entertainment (7.18%) are all high-risk factors for infectionâ€‹â€
â— (Li et al. 2020)â€‹ - â€œâ€‹Total 105 index patients and 392 household contacts were enrolledâ€¦ The
secondary attack rate of SARS-CoV-2 in household is â€‹16.3%.â€‹â€
â— (Chaw et al. 2020)â€‹ - â€œâ€‹The overall household AR is â€‹10.6%â€‹ (95% CI: 7Â·3, 15Â·1)â€‹â€
Caveatsâ€‹:
â— The detection of cases following a contact tracing study may miss some of the infections if
the timing of the study is in sync with the progression of infection of household members, and
is subject to the detection error rates of the detection method.
â— In some cases only clinical cases are identified, thus underestimating the true secondary
attack rate.
â— There could be cases in which there was either more than one infector in the household, or
that some people in the household got infected from a source other than the household.
â— The specific attack rate could change based on the awareness of the disease, hygiene and

31

physical distancing measures.

32

Case fatality rate (CFR)
Definitionâ€‹: The total number of fatalities divided by the total number of confirmed cases
Best estimateâ€‹: 1
â€‹ -15%
(uncorrected for age structure, selection bias, ascertainment rate, time delays etc.)
Methods of measurement and estimationâ€‹: Descriptive statistics based on summary of gathered data.
Possible biases not taken into account in this estimate are specified in the caveats section.
Estimatesâ€‹:
â— Global country statistics from Worldometer analyses by our open scriptâ€‹ (accessed on
31/05/2020) - We use data from all countries with more than 50 death cases and calculate the
uncorrected raw Case Fatality Rate for each country. The range represents the lowest and
highest rates observed.
Caveatsâ€‹:
Caveats associated with estimating the CFR can be divided into those affecting the numerator, i.e. the
total number of fatalities, and those affecting the denominator, i.e. the total number of cases:
â— Caveats associated with estimating the number of fatalities:
â—‹ Several key factors can affect the death toll. First, demographic parameters and
practices associated with increased or decreased risk differ greatly across societies.
For example, the capacity of the healthcare system, the average age of the population,
and the prevalence of smoking. Indeed, the majority of people dying from SARS-CoV-2
have a preexisting condition such as a cardiovascular disease or smoking â€‹(China CDC
2020)â€‹.
â—‹ There is a potential for overestimating the CFR due to a tendency to identify more
severe cases (selection bias) which will tend to overestimate the CFR.
â—‹ There is usually a delay between the onset of symptoms and death, which can lead to
an underestimate of the total number of deaths early in the progression of an
epidemic.
â—‹ Attribution of cases could sometimes be challenging, with some deaths unaccounted
for due to lack of testing or due to registration under a different cause of death. One
way to get around this issue is to quantify excess deaths relative to the average
number of deaths over the last several years.
â—‹ Different studies apply different types of corrections for a subset or all of the above
mentioned caveats. For example see (â€‹ Wu et al. 2020)â€‹.
â— Caveats associated with estimating the number of cases:
â—‹ The total number of cases detected in each country is highly dependent on the testing
capacity in the specific country. In places where death statistics are reliable, this bias
would cause countries with limited testing capacity to have a higher CFR than
countries with better testing capacity.

33

Infection fatality rate (IFR)
Definitionâ€‹: The total number of fatalities divided by the total number of infected people
Best estimateâ€‹: 0
â€‹ .3-1%
Methods of measurement and estimationâ€‹:
Estimating the total number of infected people, and thus the IFR, requires testing a random sample of
the population.
The main methods used for estimating the IFR are:
â— Testing of semi-random samples using RT-qPCR
â— Testing of semi-random samples via serology (antibody) testing
â— Model-based estimates
Because people who were infected and recovered do not show as positive with viral RNA
quantification methods, the ideal way to estimate the number of infected people is testing for the
presence of antibodies (serosurvey) against SARS-CoV-2 in random samples. As serosurveys were
not available in the early stages of the pandemic, researchers resorted to semi-random samples
tested with qPCR, or to modelling-based estimates. As of writing (May 2020), several serosurveys are
being conducted and results with IFR estimates are starting to be released.
Estimatesâ€‹:
â— Semi-random samples using RT-PCR:
â—‹ Repatriation flights from China - â€‹(Verity et al. 2020)â€‹ - â€œâ€‹We obtain an overall IFR estimate
for China of 0
â€‹ .66â€‹% (0.39%,1.33%)â€‹â€ and â€‹(Ferguson et al. 2020)â€‹ - â€œâ€‹The IFR estimates from
Verity et al.12 have been adjusted to account for a non-uniform attack rate giving an
overall IFR of 0
â€‹ .9% (â€‹ 95% credible interval 0.4%-1.4%).â€‹â€
â—‹ Diamond Princess cruise ship - â€‹(Russel et al. 2020)â€‹ - â€œâ€‹We estimated that the all-age
cIFR on the Diamond Princess was â€‹1.3%â€‹ (95% confidence interval (CI): 0.38â€“3.6) â€â€‹
â— Model-based estimates:
â—‹ Estimates for early epidemic in China (â€‹Mizumoto et al 2020â€‹) -â€‹ â€œâ€‹crude infection fatality
ratio (IFR) and timeâ€“delay adjusted IFR is estimated to be 0.04% (95% CrI:
0.03%â€“0.06%) and â€‹0.12%â€‹ (95%CrI: 0.08â€“0.17%)â€‹â€
â—‹ France (â€‹ Salje et al. 2020)â€‹ - â€œâ€‹We find 2.6% of infected individuals are hospitalized and
0.53%â€‹ die, ranging from 0.001% in those <20y to 8.3% in those >80y. â€â€‹ based on data
from the Diamond Princess cruise ship incorporated into a statistical model.
â—‹ Global â€‹(Grewelle et al. 2020)â€‹ - â€œâ€‹Applying this asymptotic estimator to cumulative
COVID-19 data from 139 countries reveals a global IFR of 1
â€‹ .04%â€‹ (CI: 0.77%,1.38%).â€‹â€
â— Serosurveys:
â—‹ Germany - (â€‹ Streeck et al. 2020)â€‹ - â€œâ€‹Die LetalitÃ¤t (case fatality rate) bezogen auf die
Gesamtzahl der Infizierten in der Gemeinde Gangelt betrÃ¤gt mit den vorlÃ¤ufigen Daten
aus dieser Studie ca. 0
â€‹ ,37 %.â€‹â€
â—‹ Denmark - (â€‹ Erikstrup et al. 2020)â€‹ - â€œâ€‹Using available data on fatalities and population
numbers a combined IFR in patients younger than 70 is estimated at 8
â€‹ 2 per 100,000 â€‹(CI:
59-154) infectionsâ€‹â€ To translate the IFR for people under 70 to the total IFR, please
consider this twitter â€‹tread
â—‹ Santa-Clara, CA, USA - (â€‹ Bendavid et al. 2020)â€‹ - Due to methodical problems with this
study the results are not indicative and thus not presented.
34

â—

Unpublished serosurveys
â—‹ New York State - â€‹linkâ€‹ (doesnâ€™t give an IFR estimate yet).
â—‹ Los Angeles County - â€‹linkâ€‹ (doesnâ€™t give an IFR estimate yet).
â—‹ Spain - lâ€‹ inkâ€‹ (doesnâ€™t give an IFR estimate yet).
â—‹ Indiana - â€‹linkâ€‹ - â€œâ€‹IUPUI scientists estimate the infection-fatality rate for the novel coronavirus in Indiana to
be â€‹0.58 percentâ€‹â€

Caveatsâ€‹:
Caveats associated with estimating the IFR can be divided into those affecting the numerator, i.e. the
total number of fatalities, and those affecting the denominator, i.e. the total number of infected
people.
â— Caveats associated with estimating the number of fatalities:
â—‹ Demographic parameters and practices associated with increased or decreased risk
differ greatly across societies. For example, the capacity of the healthcare system, the
average age of the population, and the prevalence of smoking. Indeed, the majority of
people dying from SARS-CoV-2 have a preexisting condition such as cardiovascular
disease or smoking â€‹(China CDC 2020)â€‹.
â—‹ There is usually a delay between the onset of symptoms and death, which can lead to
an underestimate of the total number of deaths early in the progression of an
epidemic.
â—‹ Attribution of cases could sometimes be challenging, with some deaths unaccounted
for due to lack of testing or due to registration under a different cause of death.
â— Caveats associated with estimating the total number of infected people:
â—‹ To get a good estimate of the prevalence infected people using a random and
representative sample of the population must be taken. In many cases, achieving such
random sampling is very challenging, and in most cases it is hard to determine how
representative the sample is. For example, people who have experienced the hallmark
symptoms of SARS-CoV-2 may be more inclined to enroll in an open study.
â—‹ When the prevalence of a disease is low, false positive results may skew the results
significantly. Many of the tests done rely on methods with non-negligible false positive
and false negative rates, and thus the reported estimates may have significant
uncertainty associated with them, if the false positive rate of the test was not
accounted for appropriately.
â—‹ The detection of infected individuals using PCR based tests is sensitive to the time at
which the test was performed relative to the progression of the disease in infected
individuals. In the first days of infection or close to recovery, the viral load of infected
individuals can be under the detection limit of PCR tests and thus infections might be
missed.
â— Caveats specific to serosurveys:
â—‹ The usage of a small number of defined SARS-CoV-2 proteins in antibody tests, e.g.
spike and/or nucleoprotein, can result in underestimates.
â—‹ The detection of infected individuals is sensitive to the time at which the test was
performed relative to the progression of the disease. It requires about 2 weeks on
average for antibodies to reach detectable levels.

35

Probability of hospitalization
Definitionâ€‹: The fraction of infected individuals that need to be hospitalized due to their conditions.
Best estimateâ€‹: â€‹ 2-4% of infected â€‹(hospitalization rate out of confirmed cases could be much higher,
e.g. 20%, as most mild cases can remain untested)
Methods of measurement and estimationâ€‹:
Descriptive statistics based on summary of gathered hospitalization data. Often divided by age
groups, gender and comorbidities. This value must be scaled to the total number of infected people,
similar to the rescaling of CFR to infer IFR. Estimation of the number of infected people requires
testing a random sample of the population. Because people who were infected and recovered do not
show as positive with viral RNA quantification methods, the ideal way to estimate the number of
infected people is testing for the presence of antibodies (serosurvey) against SARS-CoV-2 in random
samples. As these were not available in the early stages of the pandmeic, researchers resorted to
semi-random samples tested with qPCR, or to modelling-based estimates. Current estimates rely on
semi-random samples, used to correct hospitalization data.
Estimatesâ€‹:
â— The fraction of infected individuals that need to be hospitalized (based on semi-random
samples):
â—‹ Repatriation flights from Wuhan, China (adjusted for under-ascertainment rates by
comparison to other locations in China):
â–  (Verity et al. 2020)â€‹ - â€œâ€‹The demography-adjusted and
under-ascertainment-adjusted proportion of infected individuals requiring
hospitalisation ranges from â€‹1.1% iâ€‹ n the 20â€“29 years age group up toâ€‹ 18.4%â€‹ in
those 80 years and olderâ€‹â€ â€‹(Table 3 for age distribution. Assuming a uniform
attack rate. Hospitalization of only severe patients).
â–  (Ferguson et al., 2020)â€‹ - â€œâ€‹The age-stratified proportion of infections that require
hospitalisation and the infection fatality ratio (IFR) were obtained from an
analysis of a subset of cases from China (Verity et al.). These estimates were
corrected for non-uniform attack rates by age and when applied to the GB
population result in an IFR of 0.9% withâ€‹ 4.4%â€‹ of infections hospitalised (Table 1)â€‹â€
(assuming hospitalization of only severe patients))
â—‹ Vo, Italy - (â€‹ Lavezzo et al. 2020)â€‹ - â€œâ€‹ â€‹Of the 81 SARS-CoV-2 positive patients across the two
surveys, 14 required hospitalizationâ€‹ â€‹(â€‹17.2%â€‹). Their age distribution was as follows: 1
(7.1%) in the 41-50 age group, 2 (14.3%) in the 51-60 age group, 4 (28.6%) in the 61-70
age group, 5 (35.7%) in the 71-80 age group and 2 (14.3%) in the 81-90 age groupâ€‹â€
â—‹ Synthesis of total infected cases from Diamond Princess with ICU and hospitalization
data from France - (â€‹ Salje et al. 2020)â€‹ - â€œâ€‹We find that â€‹2.6% o
â€‹ f infected individuals are
hospitalized (95% CrI: 1.4-4.4), ranging from 0.09% (95% CrI: 0.05-0.2) in females under
<20y to 31.4% (95% CrI: 16.7-52.6) in males >80y.â€‹â€ (see table for distribution for sex and
age).
â—

The fraction of confirmed cases that need to be hospitalized (based on surveys)

36

â—‹

â—‹

China - â€‹(Wu and McGoogan 2020)â€‹ -â€‹ â€œâ€‹Most cases were classified as mild (81%; ie, non
pneumonia and mild pneumonia). However,â€‹ 14% w
â€‹ ere severe (ie, dyspnea, respiratory
frequency 30/min, blood oxygen saturation 93%, partial pressure of arterial oxygen to
fraction of inspired oxygen ratio <300, and/or lung infiltrates >50% within 24 to 48
hours), andâ€‹ 5% w
â€‹ ere critical (ie, respiratory failure, septic shock, and/or multiple organ
dysfunction or failure)â€‹â€
USA
â–  (Bajema et al. 2020)â€‹ -â€‹ â€œâ€‹All 210 persons who were tested were symptomaticâ€¦
Forty-two (â€‹20%â€‹)â€‹ p
â€‹ atients were hospitalized, and four (2%) were admitted to an
intensive care unit.â€‹â€
â–  Louisiana - (â€‹ Price-Haywood et al. 2020)â€‹ - â€œâ€‹A total of 3
â€‹ 9.7% â€‹of Covid-19â€“positive
patients (1382 patients) were hospitalized, 76.9% of whom were blackâ€ they
conclude: â€œBlack race was not associated with higher in-hospital mortality than
white race, after adjustment for differences in sociodemographic and clinical
characteristics on admissionâ€‹â€.
â–  Among Children in the USA - â€‹(CDC COVID-19 Response Team 2020)â€‹ â€œâ€‹Information on hospitalization status was available for 745 (29%) cases in
children aged <18 years and 35,061 (31%) cases in adults aged 18â€“64 years.
Among children with COVID-19, 147 (estimated range = â€‹5.7%â€“20%â€‹) were
reported to be hospitalized, with 15 (0.58%â€“2.0%) admitted to an ICU (Figure 2)â€‹â€.
see figure for age distribution

Caveatsâ€‹:
Caveats associated with estimating the probability of hospitalization can be divided into those
affecting the numerator i.e. the total number of individuals need to be hospitalized and those
affecting the denominator, i.e. the total number of infected people.
â—

Caveats associated with estimating the number of fatalities:
â—‹ Patients in need of hospitalization can be in different conditions. Health systems in
places which suffer from a high number of infections would tend to hospitalize only
patients with severe conditions, but in other situations patients with milder conditions
would also be hospitalized.
â—‹ Hostpitalization probability is highly dependent on age and sex, thus the overall
hospitalization in a country is affected by its population age structure, as well as the
different fraction of infected individuals (also known as â€œattack rateâ€) among different
ages.
â—‹ Underlying conditions and comorbidity are factors affecting the severity of the disease.
Their prevalence is correlated with age, but differs between countries. Thus, it may
alter the probabilities, and make it difficult to estimate it correctly for other countries.

â—

Caveats associated with estimating the total number of infected people in studies regarding
early stages of the epidemic:
â—‹ Non random sampling, common at early stages of the epidemic.
â—‹ Reliance on a small number of individuals to assess the fraction of infected
individuals is problematic, especially when it is further divided into several age groups.
Specifically, the sample size of known cohorts for young ages (<20y) is very small.

37

Comparison to other pathogensâ€‹:
â— SARS - â€‹(Rainer et al. 2004)â€‹ - very few percent do not need hospitalization â€œâ€‹Of 910 patients who
were managed without hospitalization, 6 patients had serologic evidence of SARS. Five of the
6 patients had normal chest radiographs, and 4 patients had symptoms such as myalgia,
chills, coughing, and feeling feverishâ€.

38

Probability of ICU admission
Definitionâ€‹: The fraction of hospitalized individuals that are admitted to the Intensive Care Unit (ICU).
The probability of ICU admission is also often regarded as the fraction of hospitalized patients in
critical condition (i.e., respiratory failure, septic shock, and/or multiple organ dysfunction or failure).
Best estimateâ€‹:â€‹ 10-40%â€‹ (large variation between health systems).
Methods of measurement and estimationâ€‹:
Descriptive statistics based on summary of gathered hospitalization data. Often divided by age
groups, gender and comorbidities.
Estimatesâ€‹:
â— China, Wuhan
â—‹ (D. Wang et al. 2020)â€‹ - â€‹26% o
â€‹ f hospitalized were admitted to ICUâ€‹ â€‹ â€œCompared with
patients who did not receive ICU care (n=102), patients who required ICU care (n=36)
were significantly older (median age, 66 years [IQR, 57-78] vs 51 years (IQR, 37-62];
P<.001) and were more likely to have underlying comorbiditiesâ€‹â€
â—‹ (Huang et al. 2020)â€‹ -â€‹ â€œâ€‹Of the 41 patients, 13 (â€‹32%â€‹) were admitted to the ICU because
they required high-flow nasal cannula or higher-level oxygen support measures to
correct hypoxaemiaâ€‹â€
â—‹ (Yang et al. 2020)â€‹ -â€‹ 2
â€‹ 7% â€‹of hospitalized were critical (55 of 201 includedâ€‹)â€‹ - see figure 1.
â— China - â€‹(Wu and McGoogan 2020)â€‹ - â€œâ€‹ M
â€‹ ost cases were classified as mild (81%; ie, non
pneumonia and mild pneumonia). However,â€‹ 1
â€‹ 4% were severe (ie, dyspnea, respiratory
frequency 30/min, blood oxygen saturation 93%, partial pressure of arterial oxygen to fraction of
inspired oxygen ratio <300, and/or lung infiltrates >50% within 24 to 48 hours), and 5% were
critical (ie, respiratory failure, septic shock, and/or multiple organ dysfunction or failure)â€‹â€ â€‹ The
estimate of â€‹25%â€‹ is based on dividing the number of critical cases by the number of severe
cases (similar to critical out of hospitalized, as mostly only severe cases are hospitalized in a
crowded health system)
â— Lombardy Region, Italyâ€‹ - (â€‹ Grasselli, Pesenti, and Cecconi 2020)â€‹ - â€œâ€‹Theâ€‹ p
â€‹ roportion of ICU
admissions represents 12% of the total positive cases, and 1
â€‹ 6% â€‹of all hospitalized patients. This
rate is higher than what was reported from China, where only 5% of patients who tested positive
for COVID-19 required ICU admissionâ€‹â€.
â— France, analysis of probability by age, based on data combined with incidents from Diamond
Princess cruise ship - â€‹(Salje et al. 2020)â€‹ - â€œâ€‹Once hospitalized, â€‹18.2%â€‹ (95% CrI: 18.0%-18.6%)
patients enter ICU after a mean delay of 1.5 days (Figure S1). There is an increasing probability
of entering ICU with age - however, this drops for those >70y (Figure 2B, Table S2).â€‹.â€â€‹ (see table
for distribution for sex and age).
â— New York - â€‹(Richardson et al. 2020)â€‹ - from Table 5, â€‹22% â€‹of hospitalized patients (1281/5700)
were admitted to the ICU.
â— China, Shanghai - (â€‹ Chen et al. 2020)â€‹ - â€œâ€‹A total of 22 (â€‹8.8%â€‹) patients were admitted in ICU 8.5
Â±4.0 days after onset of symptomsâ€‹â€.
â— USA (end of January) - (â€‹ Bajema et al. 2020)â€‹ - â€‹10% â€‹of hospitalized were admitted to ICU.
â€œForty-two (20%) patients were hospitalized, and four (2%) were admitted to an intensive care
unit.â€
â— Louisiana, USA - â€‹(Price-Haywood et al. 2020)â€‹ - â€œâ€‹ â€‹More than one thirdâ€‹ of admitted patients (474
patients) received care in an intensive care unit, among whom 80.2% were black patients.â€â€‹ from
table 2: 29.5% of White Non-Hispanic patients and 35.7% of Black Non-Hispanic patients

39

â—

â—

Georgia, USA - â€‹(Gold et al. 2020)â€‹ - â€‹â€œIntensive care unit (ICU) admission occurred among 119
(â€‹39.0%â€‹) patients and increased significantly with age group: among patients aged â‰¥65 years,
53.8% were admitted to an ICU (p<0.001). Overall, 92 (30.2%) patients received IMV,
representing 77.3% of those admitted to an ICU.â€â€‹ Similar fractions among Whilat and Black
patients.
Specific for children:
â—‹ China - â€‹(Dong et al. 2020)â€‹ - â€‹ â€œâ€‹ The proportions of severe and critical cases were 10.6%,
7.3%, 4.2%, 4.1%, and 3.0% for the age groups ,1, 1 to 5, 6 to 10, 11 to 15, and >16 years,
respectively...with much fewer being severe and critical cases (5.8%) than in adult
patients (18.5%)â€ B
â€‹ ased on Table 2, we estimate a probability of â€‹10%â€‹ for ICU
admissions from the ratio of c
â€‹ ritical cases to cases in severe or critical condition
â—‹ USA - â€‹(CDC COVID-19 Response Team 2020)â€‹ a
â€‹ bout 1
â€‹ 0% â€‹-â€‹ â€‹â€œInformation on
hospitalization status was available for 745 (29%) cases in children aged <18 years and
35,061 (31%) cases in adults aged 18â€“64 years. Among children with COVID-19, 147
(estimated range = 5.7%â€“20%) were reported to be hospitalized, with 15 (0.58%â€“2.0%)
admitted to an ICU (Figure 2)â€â€‹.
(see figure for age distribution)

Caveatsâ€‹:
â— Patients in need of hospitalization can be in different physical conditions. Health systems in
places which suffer from a high number of infections would tend to hospitalize only patients
with severe conditions and thus have higher probability of ICU admission.
â— Both hostpitalization and ICU admission probabilities are highly dependent on age and sex,
thus the overall hospitalization of a country is affected by its population age structure, as well
as the different attack rate among different ages.
â— Underlying conditions and comorbidity are factors affecting the severity of the disease. Their
prevalence is correlated with age, but differs between countries. Thus, it may alter the
probabilities, and make it difficult to estimate it correctly for other countries.
Comparison to other pathogensâ€‹:
â— SARS - â€‹(Joynt and Yap 2004)â€‹ -â€‹ â€œâ€‹Approximatelyâ€‹ 20%â€‹ of patients with severe acute respiratory
syndrome (SARS) develop respiratory failure that requires admission to an intensive care unit
(ICU)â€â€‹.
â— MERS - (â€‹ Matsuyama et al. 2016)â€‹ -â€‹ â€‹â€œThe risks of ICU admission and mechanical ventilation
ranged from 44% to 100% and from 25% to 100%, with pooled estimates atâ€‹ 78%â€‹ and 73%,
respectivelyâ€

40

Probability of death in ICU
Definitionâ€‹: The fraction of infected patients that were admitted to the Intensive Care Unit (ICU) who
didnâ€™t survive.
Best estimateâ€‹:â€‹ 20%-80%
Methods of measurement and estimationâ€‹:
Descriptive statistics based on summary of gathered hospitalization data. Often divided by age
groups, gender, ethnicity and comorbidities.
Estimatesâ€‹:
â— In health systems crowded by the outbreak:
â—‹ China, Wuhan
â–  (D. Wang et al. 2020)â€‹ - â€‹17% o
â€‹ f patients admitted to ICUâ€‹ h
â€‹ ave died â€‹â€œOf the 36
patients admitted to the ICU, 11 were still in the ICU, 9 had been discharged to
home, 10 had been transferred to the general wards, and 6 had diedâ€.
â–  (Huang et al. 2020)â€‹ - â€œâ€‹ 1
â€‹ 3 (32%) patients were admitted to an ICU and six (â€‹15%â€‹)
diedâ€.
â–  (Yang et al. 2020)â€‹ - â€œâ€‹ 32 (â€‹61.5%â€‹) of critically ill patients had died at 28 days. Of all
included patients, 37 (71%) required mechanical ventilation and 35 (67%) had
ARDS.â€
â—‹ New York, USA - â€‹(Richardson et al. 2020)â€‹ â€‹- â€‹According to Table 5, 7
â€‹ 8% â€‹(291/373) of the
ICU patients who had outcomes (been discharged or died) have died. Due to the
overcrowding of the health system, a
â€‹ similar number of patients have died without
being admitted to the ICUâ€‹ - â€‹â€œAmong the 2634 patients who were discharged or had died
at the study end point, during hospitalization, 373 (14.2%) were treated in the ICU, 320
(12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidney
replacement therapy, and 553 (â€‹21%â€‹) died (Table 5).â€
â—‹ Lombardy Region, Italy - â€‹(Grasselli et al. 2020)â€‹ - 6
â€‹ 1%â€‹ of ICU patients with outcomes
have died (405/661). 26% of admitted (including those stille in ICU). This fraction may
be overestimated due to censoring effects. â€œâ€‹ Among the 1581 patients with ICU
disposition data available as of March 25, 2020, 920 patients (58% [95% CI, 56%-61%])
were still in the ICU, 256 (16% [95% CI, 14%-18%]) were discharged from the ICU, and 405
(26% [95% CI, 23%-28%]) had died in the ICU. Older patients (n = 786; age 64 years) had
higher mortality than younger patients (n = 795; age 63 years) (36% vs 15%; difference,
21% [95% CI, 17%-26%]; P < .001)â€‹â€
â—‹ Britain - â€‹(ICNARC 2020c)â€‹ - from Table 10, â€‹43% (â€‹ 3481/8060) have died in critical care
(out of those with outcomes). See table for separation by age, ethnicity , gender and
more.
â— In less crowded health systems:
â—‹ China, Shanghai - â€‹(Chen et al. 2020)â€‹ - 2
â€‹ 2% â€‹of ICU patients with outcomes have died
(2/9).â€œâ€‹A total of 22(8.8%) patients were admitted in ICU... To the time of submission, a
total of 215 (86.3%) patients were discharged after 16(12â€“20) days hospitalization, 13
patients were still in ICU and 19 patients in stable condition. A total of 2 patients died
(0.8%).â€‹â€.
â—‹ Georgia, USA - â€‹(Gold et al. 2020)â€‹ - â€œâ€‹As of April 24, 2020, 24 (7.9%) patients remained
hospitalized, including 14 (58.3%) in the ICU and nine (37.5%) on IMV. Overall, the
estimated percentage of deaths among patients who received ICU care ranged from

41

37.0%â€‹, assuming all remaining ICU patients survived, to 48.7%, assuming all remaining
ICU patients diedâ€.
â— Probability of death of h
â€‹ ospitalizedâ€‹ patients:
â—‹ France, analysis of probability by age, based on data combined with incidents from
Diamond Princess - (â€‹ Salje et al. 2020)â€‹ - â€â€‹ O
â€‹ verall, â€‹18.1%â€‹ (95% CrI: 17.8â€“18.4) of
hospitalizedâ€‹ individuals go on to dieâ€‹â€. Very close to the fraction of admitted to ICU
(18.2%).
â—‹ Louisiana, USA - â€‹(Price-Haywood et al. 2020)â€‹ - from table 2, 2
â€‹ 5% â€‹of â€‹hospitalized
patients with outcomes have died (326/1320). Among White patients about 31% die,
while only 22% among Black patients.
Caveatsâ€‹:
â— Patients in need of hospitalization can be in different conditions. Health systems in places
which suffer from a high number of infections would tend to hospitalize only patients with
severe conditions and thus have higher probability of ICU admission. Moreover, overcrowding
of ICU may result in critical patients not being admitted to ICU at all.
â— Censoring of ICU outcomes (i.e. outcomes being available for only part of the patients during
the spread) may bias the death probability to higher values as the duration of stay in ICU is
longer for patients who recover. This is also shown in previous reports from ICNARC (â€‹ICNARC
2020aâ€‹, Iâ€‹ CNARC 2020bâ€‹).
â— Hostpitalization, ICU admission and death probabilities are highly dependent on age and sex,
thus the overall hospitalization in a country is affected by its population age structure, as well
as the different attack rate among different ages groups.
â— Underlying conditions and comorbidity are factors affecting the severity of the disease. Their
prevalence is correlated with age, but differs across countries.
Comparison to other pathogensâ€‹:
â— SARS - â€‹(Joynt and Yap 2004)â€‹ -â€‹ â€œâ€‹Long-term mortality for patients admitted to the ICU ranges
from â€‹30% to 50%â€‹.â€â€‹.
â— MERS - â€‹(Matsuyama et al. 2016)â€‹ -â€‹ From fig 4, among four studies that consider only ICU
cases, the death probability ranged from â€‹58% to 75%â€‹.

42

RT-qPCR False Positive Rate
Definitionâ€‹: The fraction of uninfected people who test positive for SARS-CoV-2 via RT-qPCR. The false
positive rate is often reported as â€œspecificityâ€ which is the fraction of negatives test results that are
true negatives (i.e. uninfected). The false positive rate (in %) is 100% - specificity.
Best estimateâ€‹: 0.2-3% corresponding to a specificity of 97-99.8%.
Methods of measurement and estimationâ€‹: Testing of samples from patients known not to have
SARS-CoV-2 based on various modes of testing, patients who could not have had SARS-CoV-2 due to
sample collection prior to late 2019, and samples from animals known not to contract SARS-CoV-2.
Estimatesâ€‹:
â— RT-qPCR testing of uninfected patients and/or animals
â—‹ (Jiang et al. 2020)â€‹ - â€‹â€œThe sensitivity and specificity of RT-PCR for pharyngeal were 78.2%
and 98.8%. Positive predictive value and negative predictive value were 91.9% and 96.2.
and Youdenâ€™s index was 0.770, which indicated overall performance.â€œ â€‹A specificity of
98.8% corresponds to a false positive rate of â€‹1.2%â€‹.
â—‹ (Wernike et al. 2020)â€‹ â€œIf we assume a best-case scenario for specificity based on these
results for the A-3 or B / E-Sarbeco setting, the diagnostic specificity was calculated as
0.9756 (40/41; table 1).â€œ A specificity of 0.9756 corresponds to a false positive rate of
2.44%â€‹.
â— Comparison to established RT-qPCR testing for other RNA viruses
â—‹ (Merckx et al. 2017)â€‹ Table 2 gives a pooled specificity of 99.2% (95% confidence
interval of 98.6-99.7%) for influenza A and 99.4% (98.9-99.8) for influenza B. A
specificity of 99.2% and 99.4% corresponds to a false positive rate of â€‹0.8%â€‹ and â€‹0.6%â€‹.
â—‹ (Cohen and Kessel 2020)â€‹ â€œIn all, 336 of the 10,538 negative samples (3.2%) were
reported as positive. We considered two data sets comprising all 43 EQAs (full data
set), and the 37 EQAs that analyzed at least 100 negative samples (subset). FPRs in
each EQA ranged from 0-16.7% for the full data set, and 0- 8.1% for the subset... The
median and interquartile range were lower for the full data set (median=â€‹2.3%â€‹,
interquartile range=0.8-4.0%) than for the subset (median=2.5%, interquartile
range=1.2-4.0%).â€
Caveats:
â— RT-qPCR is used to quantify the amount of viral genomic RNA in patient samples. It works by
monitoring the progress of a reverse-transcriptase (RT) PCR via the fluorescence of a DNA
binding dye (or an oligonucleotide probe). Since DNA accumulates over the course of the
reaction and dye fluorescence is increased by DNA binding, fluorescence reports on reaction
progress. It is common to report â€œcycle thresholdâ€ or â€œquantification cycleâ€ values (Câ€‹tâ€‹ or Câ€‹q
values) for RT-qPCR. Câ€‹qâ€‹ values report the cycle number at which dye fluorescence crossed a
predefined threshold. The earlier the threshold is crossed, the lower the Câ€‹qâ€‹ value and the more
RNA was in the sample. A positive test is one with a Câ€‹qâ€‹ value beneath a prespecified threshold
(e.g. Ct < 40), though this threshold will vary from between specific tests (e.g. which primers
were used).
â— The false positive rate or specificity of RT-qPCR testing is only rarely reported in studies
investigating RT-qPCR tests of SARS-CoV-2.

43

â—

â—

Error rates can depend strongly on the primer sets used, as documented in â€‹(Wernike et al.
2020)â€‹ and â€‹(Barra et al. 2020)â€‹, the latter of which is quoted here:â€‹ â€œWe observed consistent false
positive results for N and N2 (60 out of 60 samples for both). N3 assay generated false positive
signal or inconclusive results in 13 out of 60 tested samples.â€
False positives are likely to be dominated by errors in sample handling, as false positives are
uncommon in RT-qPCR in general.

44

RT-qPCR False Negative Rate
Definitionâ€‹: The fraction of people infected with SARS-CoV-2 who test negative by a single RT-qPCR
test. The false negative rate is often reported as â€œsensitivityâ€ which is the fraction of negative test
results that are true positives (i.e. were previously infected). The false negative rate (in %) is therefore
100% - sensitivity.
Best estimateâ€‹: 5-30â€‹% â€‹depending on choice of kit and primers
Methods of measurement and estimationâ€‹: RT-PCR testing of confirmed SARS-CoV-2 patients in the
days immediately following the onset of symptoms. Patients are typically identified via an initial
positive RT-qPCR test and a second diagnostic method, e.g. a CT scan of the lungs.
Estimatesâ€‹:
â— RT-qPCR testing of confirmed SARS-CoV-2 patients
â—‹ (J. Zhao Jr. et al. 2020)â€‹ Figure 2, Table 2 and results - â€œâ€‹ As the results shown in Figure 2
and Table 2, in the early phase of illness within 7-day since onset, the RNA test had the
highest sensitivity of 66.7%, whereas the antibody assays only presented a positive rate
of 38.3%.â€â€‹ Sensitivity of 66.7% corresponds to a false negative rate of 3
â€‹ 3.3%â€‹.
â—‹ (Jiang et al. 2020)â€‹ - â€‹â€œCombination of RT-PCR and CT has the higher sensitivity
(91.9%,79/86) than RT-PCR alone (78.2%ï¼Œ68/87) or CT alone (66.7%, 54 of 81) or
combination of two RT-PCR tests (86.2%,75/87).â€œ â€‹Sensitivity of 78.2% corresponds to a
false negative rate of 2
â€‹ 2.8%â€‹.
â—‹ (Arnaout et al. 2020)â€‹ -â€‹ â€œFor example, an assay with LoD of 1,000 copies/mL, such as that
of the CDC assay (8) or Genmark ePlex EUA (9), is expected to detect 77%, or 3 in 4, of
infected individuals, for a false-negative rate of 2
â€‹ 2%â€‹. With an LoD of 6,250 copies/mL,
the LabCorp COVID-19 RT-PCR EUA test has an estimated clinical sensitivity of 67% and
a false-negative rate of 3
â€‹ 3%â€‹, missing approximately 1 in 3 infected individualsâ€
â— Evaluation of multiple rounds of patient testing
â—‹ (Li et al. 2020)â€‹ â€œAmong the 384 patients with initial negative results, the second test
was performed. For these patients, the test results were positive in 48 cases (12.5%),
dubiously positive in 27 patients (7.0%), negative in 280 patients (72.9%), and results
were not available for 29 patients (7.6%) (Figure 1B and Table 2). Among the patients
with initial nonâ€positive results, seven patients were eventually confirmed with
COVIDâ€19 by three repeated swab PCR tests, four were confirmed by four repeated
tests, and one was confirmed by five repeated tests.â€ Simple calculation gives a
nominal false negative rate of at least 12/384 â‰ˆ 3
â€‹ %â€‹ and at most 48/384 â‰ˆ â€‹12%â€‹.
â— Meta-analysis of published test results
â—‹ (Wikramaratna et al. 2020)â€‹ - â€œâ€‹ The probability of a positive test decreases with the
number of days past symptom onset; for a nasal swab, the percentage chance of a
positive test declines from 94.39% [86.88, 97.73] on day 0 to 67.15% [53.05, 78.85] by
day 10.â€ T
â€‹ his implies that the false negative rate increases from â€‹5.61% 0
â€‹ days after
symptom onset to â€‹32.85%â€‹ 10 days after symptom onset
â—‹ (Kucirka et al. 2020)â€‹ â€œOver the 4 days of infection before the typical time of symptom
onset (day 5), the probability of a false negative result in an infected person decreases
from 100% (95% CI, 100% to 100%) on day 1 to 67% (CI, 27% to 94%) on day 4, although
there is considerable uncertainty in these numbers. On the day of symptom onset, the
median false-negative rate was â€‹38%â€‹ (CI, 18% to 65%).â€
â— Comparison to established RT-qPCR testing for other RNA viruses

45

â—‹

(Merckx et al. 2017)â€‹ Figure 3 gives a pooled sensitivity of 92% (95% confidence interval
of 85â€“96%) for influenza A and 95% (87-99%) for influenza B. Sensitivity of 92% and
95% corresponds to a false negative rate of â€‹8% a
â€‹ nd â€‹5%â€‹.

Caveats:
â— RT-qPCR is used to quantify the amount of viral genomic RNA in patient samples. It works by
monitoring the progress of a reverse-transcriptase (RT) PCR via the fluorescence of a DNA
binding dye (or an oligonucleotide probe). Since DNA accumulates over the course of the
reaction and dye fluorescence is increased by DNA binding, fluorescence reports on reaction
progress. It is common to report â€œcycle thresholdâ€ or â€œquantification cycleâ€ values (Câ€‹tâ€‹ or Câ€‹q
values) for RT-qPCR. Câ€‹qâ€‹ values report the cycle number at which dye fluorescence crossed a
predefined threshold. The earlier the threshold is crossed, the lower the Câ€‹qâ€‹ value and the more
RNA was in the sample. A positive test is one with a Câ€‹qâ€‹ value beneath a prespecified threshold
(e.g. Ct < 40), though this threshold will vary from between specific tests (e.g. which primers
were used).
â— There is an important distinction between empirical and analytical sensitivity. The analytical
sensitivity is also known as the â€œlimit of detection.â€ The limit of detection is related to
empirical sensitivity (equivalently, false negative rate) in that patient samples containing
amounts of SARS-CoV-2 RNA beneath the limit of detection will nearly always produce false
negative results. The limit of detection is measured by adding known quantities of synthetic
SARS-CoV-2 RNA into an RT-qPCR reaction; the lowest measurable quantity is the limit of
detection. These values are expressed in units of viral RNA copies per reaction and vary
depending on which primers and kits are used â€‹(Vogels et al. 2020)â€‹. However, analytical
sensitivities are usually measured in the absence of patient sputum or saliva, which might
affect PCR reactions. Moreover, for patient samples, the true quantity of RNA is always
unknown and inter-individual variation in physiology and genetics may contribute to variation
in viral titers in sputum or saliva. Empirical sensitivities and false negative rates reported
above therefore represent RT-qPCR studies conducted on confirmed COVID-19 patients.
However, since confirmed COVID-19 patients are nearly always symptomatic and often
selected from hospital admissions, there may be a selection bias towards sicker individuals
with higher viral loads, which would tend to yield under-estimates of the false negative rate. It
is therefore very striking that reported false negative rates sometimes exceed 30%.
â— The false negative rate of RT-qPCR testing appears to depend greatly on sample handling,
storage and protocol details, for example the choice of primers and kits â€‹(Barra et al. 2020;
Vogels et al. 2020)â€‹, which might explain the wide range of estimates.
â— Viral titers depend strongly on how much time has passed since infection. Generally, viral
titers in patient samples increase over time until reaching a maximum at â‰ˆ5 days after
infection, after which titers decrease again â€‹(Zhao et al. 2020; Wikramaratna et al. 2020;
Larremore et al. 2020)â€‹. When titers are beneath the limit of detection, one should not expect
RT-qPCR to detect the infection. At the moment of infection, for example, patients sputum and
saliva should test negative because there has been no time for the virus to replicate in their
body. It is also important to note that this represents an inferred description of a â€œtypicalâ€
patient and that there is certainly inter-individual variability in maximal viral load and sputum
production that will affect individual likelihoods of diagnosis of RT-qPCR.
â— Double testing of the same patient may substantially reduce the false negative rate and is
recommended by the CDC and several references (â€‹ Jiang et al. 2020)â€‹. However, the
quantitative effect of multiple samples of the same individuals usually lowers the false
negative rate to a lesser degree than expected when tests are statistically independent. For
example, (â€‹ Jiang et al. 2020)â€‹ report a 2
â€‹ 2% false negative rate for a single test and 14% false

46

â—

negative rate for a double test. If we assume statistical independence, then the false negative
rate for two tests should be 0.22â€‹2â€‹ â‰ˆ 5%. The empirical value of 14% represents an 8%
reduction in the false negative rate, which is about Â½ of the 17% reduction expected when
tests are statistically independent. This lower-than-expected reduction could stem from the
repeat tests not being completely independent, due, for example, to the timing of tests relative
to the start of infection or the time the tests are taken during the time course of the infection
of the infected individual.
Similarly, confirmatory testing by CT scan â€‹(Jiang et al. 2020)â€‹ or antibody tests (â€‹ Zhao et al.
2020)â€‹ reduce the false negative rate as well.

47

Duration of PCR positivity
Definitionâ€‹: The number of days post symptom onset for which >50% of infected people test positive
by RT-qPCR. Notably, viral shedding and, hence, PCR-positivity, begins several days after infection.
Best estimateâ€‹: â‰ˆ7-9 days
Methods of measurement and estimationâ€‹: RT-PCR testing of confirmed SARS-CoV-2 patients in the
days following the onset of symptoms. Patients are typically identified via an initial positive RT-qPCR
test and potentially a second diagnostic method, e.g. a CT scan of the lungs.
Estimatesâ€‹:
â— RT-qPCR testing of confirmed SARS-CoV-2 patients
â—‹ (J. Zhao Jr. et al. 2020)â€‹ Figure 2, Table 2 and results - â€œâ€‹ A
â€‹ s the results shown in Figure 2
and Table 2, in the early phase of illness within 7
â€‹ â€‹-day since onset, the RNA test had the
highest sensitivity of 66.7%, whereas the antibody assays only presented a positive rate
of 38.3%.â€‹â€
â—‹ (Young et al. 2020)â€‹ - â€œâ€‹ A
â€‹ mong the 18 hospitalized patients with PCR-confirmed
SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was
an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx
was prolonged for â€‹7â€‹ days or longer among 15 (83%).â€‹â€
â—‹ (To et al. 2020)â€‹ Figure 2 and text - â€œâ€‹Of the 21 patients who survived, seven (33%) had
viral RNA detected for 20 days or longer after symptom onset.â€‹â€
â— Re-analysis of published PCR testing results
â—‹ (Wikramaratna et al. 2020)â€‹ Figure 3, which replots data from â€‹(Bi et al. 2020)
Caveats:
â— The period of >50% PCR positivity may not begin immediately after onset of symptoms. For
example, one reference report a â‰ˆ1 day lag from symptom onset to 50% PCR positivity (â€‹ Zhao
et al. 2020)â€‹, but this reference had access to only one patient whose reported symptoms
began on the same day as testing.
â— Error rates associated with RT-qPCR testing will depend greatly on sample handling, storage
and protocol details, which might explain the wide range of estimates.
â— As with all PCR testing, error rates and limits of detection will depend on the choice of primers
and kits â€‹(Barra et al. 2020; Vogels et al. 2020)â€‹.

48

Antibody Test False Positive Rate
Definitionâ€‹: The fraction of uninfected people who test positive for SARS-CoV-2 antibodies. The false
positive rate is often reported as â€œspecificityâ€ which is the fraction of negatives test results that are
true negatives (i.e. uninfected). The false positive rate (in %) is 100% - specificity.
Best estimateâ€‹: 0.1-15%, corresponding with a specificity of â‰ˆ85-99.8%.
Methods of measurement and estimationâ€‹: testing of samples from patients known not to have
SARS-CoV-2 because the samples were taken before the epidemic began (e.g. banked blood
donations and patient sera).
Estimatesâ€‹:
â— Testing of pre-epidemic samples
â—‹ (Whitman et al. 2020)â€‹ - â€œâ€‹ Test specificity ranged from 84.3-100.0% in pre-COVID-19
specimens.â€ â€‹A specificity of 84.3%-100% corresponds to a false positive rate of
0%-15.7%â€‹.
â—‹ (J. Zhao Jr. et al. 2020)â€‹ - â€œâ€‹ The specificity of the assays for Ab, IgM and IgG was
determined as 99.1% (211/213), 98.6% (210/213) and 99.0% (195/197) by testing of
samples collected from healthy individuals before the outbreak of SARS-CoV-2â€â€‹. A
specificity of 99.1%, 98.6% and 99% corresponds to a false positive rate of â€‹0.9%â€‹, â€‹1.4%
and â€‹1%â€‹.
â—‹ (Bryan et al. 2020)â€‹ - â€‹â€œWe tested 1,020 serum specimens collected prior to SARS-CoV-2
circulation in the United States and found one false positive, indicating a specificity of
99.90%.â€ â€‹A specificity of 99.9% corresponds to a false positive rate of 0
â€‹ .1%â€‹.
â—‹ (JÃ¤Ã¤skelÃ¤inen et al. 2020)â€‹ â€œThe specificity and sensitivity values of the commercial
tests against MNT, respectively, were as follows: 95.1%/80.5% (Abbott Architect
SARS-CoV-2 IgG), 94.9%/43.8% (Diasorin Liaison SARS-CoV-2 IgG), 68.3%/87.8%
(Euroimmun SARS-CoV-2 IgA), 86.6%/70.7% (Euroimmun SARS-CoV-2 IgG),
74.4%/56.1% (Acro 2019-nCoV IgG), 69.5%/46.3% (Acro 2019-nCoV IgM), 97.5%/71.9%
(Xiamen Biotime SARS-CoV-2 IgG), and 88.8%/81.3% (Xiamen Biotime SARSCoV-2
IgM).â€ A specificity of 95.1%, 94.9%, 68.3% and 74.4%, 69.5%, 97.5% and 88.8%
corresponds to a false positive rate of 4
â€‹ .9%â€‹, 5
â€‹ .1%â€‹ and 3
â€‹ 1.7%â€‹, â€‹25.6%â€‹, 3
â€‹ 0.5%â€‹, and
11.2%â€‹. We consider kits with especially high values as outliers and not representative
for the best estimate above.
â— Comparison to established immunological testing for other RNA viruses
â—‹ (Merckx et al. 2017)â€‹ Table 2 gives a pooled specificity estimate of 99.4 (95%
confidence interval 99.1-99.7%) for influenza A and 99.8% (99.7-99.9%) for influenza B.
A specificity of 99.4%, and 99.8% corresponds to a false positive rate of â€‹0.6%â€‹ and
0.2%â€‹.
Caveats
â— Serology tests assay the presence of antibodies in the bloodstream. As antibodies only
develop â‰ˆ10 days after the onset of symptoms (â€‹ Zhao et al. 2020; To et al. 2020)â€‹ these tests
are not useful for diagnosing patients with active disease. Rather, serology testing or
â€œserosurveysâ€ are used to measure the incidence of the infection in the population at large in
order to determine the state of the epidemic. Because these tests have non-trivial
false-positive and false-negative rates, great care should be taken in interpreting the results of
serosurveys.

49

â—
â—

Since antibodies take â‰ˆ10 days to develop. However, the timing of infection is often unknown.
In practice, therefore, the timing of the test will be a major factor affecting test results.
Error rates will depend both on which testing approach (or specific kit) is used as well as the
sample collection, storage and sample handling procedures. We report a range that includes
kit-to-kit variability as reported in â€‹(Whitman et al. 2020; JÃ¤Ã¤skelÃ¤inen et al. 2020)â€‹ but this does
not include between-lab differences in sampling, transport and preparation. Some kits have
been shown to perform worse than the reported range, see (â€‹ JÃ¤Ã¤skelÃ¤inen et al. 2020)â€‹.

50

Antibody Test False Negative Rate
Definitionâ€‹: The fraction of previously infected people who test negative for SARS-CoV-2 antibodies.
Since it takes time for antibodies to develop, we report a false negative rate estimate for tests
conducted 10 or more days after symptoms. The false negative rate is often reported as â€œsensitivityâ€
which is the fraction of negative test results that are true positives (i.e. were previously infected). The
false negative rate (in %) is 100% - sensitivity.
Best estimateâ€‹: 10-50%, corresponding to a selectivity of 50-90% 10+ days after symptom onset.
Methods of measurement and estimationâ€‹: testing of samples from patients known to have
SARS-CoV-2 by a combination of RT-qPCR and clinical markers (e.g. symptoms and CT scans). One
study â€‹(JÃ¤Ã¤skelÃ¤inen et al. 2020)â€‹ compares serology tests to assays testing the neutralization of virus
by patient sera. In this particular case, we report numbers for patients irrespective of time post
symptoms as the control (viral neutralization) directly tests for the presence of neutralizing
antibodies.
Estimatesâ€‹:
â— Testing of samples from patients with confirmed SARS-CoV-2 10+ days after onset of
symptoms.
â—‹ Table 2 of (â€‹ Whitman et al. 2020)â€‹ gives sensitivity as a function of days since
patient-reported onset of symptoms. Note that the sample number is small in this
study (< 30 for all bins).
â—‹ (J. Zhao Jr. et al. 2020)â€‹ Figure 2 and results section - â€œâ€‹ In samples from patients during
day 8-14 after onset, the sensitivities of Ab (89.6%), IgM (73.3%) and IgG (54.1%) were all
higher than that of RNA test (54.0%).â€ S
â€‹ ensitivity of 89.6% and 54.1% corresponds to a
false negative rate of 1
â€‹ 0.4%â€‹ and â€‹45.9%â€‹.
â—‹ (Bryan et al. 2020)â€‹ -â€‹ â€œThe sensitivity of the assay from the estimated day of symptom
onset for the 125 patients included in our chart-review study was 53.1% (95% CI
39.4%-66.3%) at 7 days, 82.4% (51.0-76.4%) at 10 days, 96.9% (89.5-99.5%) at 14 days,
and 100% (95.1%-100%) at day 17 using the manufacturerâ€™s recommended cutoff of
1.4.â€ S
â€‹ ensitivity of 82.4% and 96.9% corresponds to a false negative rate of 1
â€‹ 1.6%â€‹ and
3.1%â€‹.
â— Comparison to viral neutralization measurement
â—‹ (JÃ¤Ã¤skelÃ¤inen et al. 2020)â€‹ â€œThe specificity and sensitivity values of the commercial
tests against MNT, respectively, were as follows: 95.1%/80.5% (Abbott Architect
SARS-CoV-2 IgG), 94.9%/43.8% (Diasorin Liaison SARS-CoV-2 IgG), 68.3%/87.8%
(Euroimmun SARS-CoV-2 IgA), 86.6%/70.7% (Euroimmun SARS-CoV-2 IgG),
74.4%/56.1% (Acro 2019-nCoV IgG), 69.5%/46.3% (Acro 2019-nCoV IgM), 97.5%/71.9%
(Xiamen Biotime SARS-CoV-2 IgG), and 88.8%/81.3% (Xiamen Biotime SARSCoV-2
IgM).â€ Sensitivity of 80.5% and 43.8%, 87.8%, 70.7%, 56.1%, 46.3%, and 71.9%
corresponds to a false negative rate of â€‹19.5%â€‹, â€‹56.2%â€‹,â€‹ 12.2%â€‹,â€‹ 29.3%â€‹,â€‹ 43.9%, 53.7%â€‹, and
28.1%â€‹. We consider kits with especially high values as outliers and not representative
for the best estimate above.
â— Comparison to established immunological testing for other RNA viruses
â—‹ (Merckx et al. 2017)â€‹ Table 2 gives a pooled sensitivity estimate of 54.4% (95%
confidence interval 48.9-59.8%) for influenza A and 53.2% (41.7-64.4%) for influenza B.

51

Sensitivity of 54.4% and 53.2% corresponds to a false negative rate of â€‹45.6%â€‹ and
46.8%â€‹.
Caveats
â— Serology tests assay the presence of antibodies in the bloodstream. As antibodies only
develop ~10 days after the onset of symptoms (â€‹ Zhao et al. 2020; To et al. 2020)â€‹ these tests
are not considered useful for diagnosing patients with active disease. Rather, serology testing
or â€œserosurveysâ€ are used to measure the incidence of the infection in the population at large
in order to determine the state of the epidemic. Because these tests have non-trivial
false-positive and false-negative rates, great care should be taken in interpreting the results of
serosurveys.
â— Since antibodies take ~10 days to develop. However, the timing of infection is often unknown.
In practice, therefore, the timing of the test will be a major factor affecting test results.
â— As above, error rates will depend both on which testing approach (or specific kit) is used as
well as the sample collection, storage and sample handling procedures. We report a range
that includes kit-to-kit variability as reported in â€‹(Whitman et al. 2020; JÃ¤Ã¤skelÃ¤inen et al. 2020)
but this does not include between-lab differences in sampling, transport and preparation.
â— The range we report is the empirical range from (â€‹ Whitman et al. 2020; JÃ¤Ã¤skelÃ¤inen et al.
2020)â€‹ and does not include statistical estimates of uncertainty. A statistical estimate of the
95% confidence interval on test sensitivity gives much wider ranges.

52

References
(From definitions and caveates. Measurements & estimates have direct links to papers).
Barra, Gustavo Barcelos, Ticiane Henriques Santa Rita, Pedro Goes Mesquita, Rafael Henriques
Jacomo, and Lidia Freire Abdalla Nery. 2020. â€œAnalytical Sensibility and Specificity of Two
RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow.â€ m
â€‹ edRxivâ€‹.
medRxiv. https://doi.org/â€‹10.1101/2020.03.07.20032326â€‹.
Cohen, Andrew N., and Bruce Kessel. 2020. â€œFalse Positives in Reverse Transcription PCR Testing for
SARS-CoV-2.â€ m
â€‹ edRxivâ€‹, May, 2020.04.26.20080911.
Cori, Anne, Neil M. Ferguson, Christophe Fraser, and Simon Cauchemez. 2013. â€œA New Framework
and Software to Estimate Time-Varying Reproduction Numbers during Epidemics.â€ â€‹American
Journal of Epidemiologyâ€‹ 178 (9): 1505â€“12.
Ferretti, Luca, Chris Wymant, Michelle Kendall, Lele Zhao, Anel Nurtay, Lucie Abeler-DÃ¶rner, Michael
Parker, David Bonsall, and Christophe Fraser. 2020. â€œQuantifying SARS-CoV-2 Transmission
Suggests Epidemic Control with Digital Contact Tracing.â€ S
â€‹ cienceâ€‹, March.
https://doi.org/â€‹10.1126/science.abb6936â€‹.
Folkhalsomyndigheten. 2020. â€œSweden: Estimate of the Effective Reproduction Number.â€
Folkhalsomyndigheten.
Imai, Natsuko, Anne Cori, Ilaria Dorigatti, Marc Baguelin, Christl A. Donnelly, Steven Riley, and Neil M.
Ferguson. n.d. â€œReport 3: Transmissibility of 2019-nCoV.â€ https://doi.org/â€‹10.25561/77148â€‹.
JÃ¤Ã¤skelÃ¤inen, Anne J., Suvi Kuivanen, Eliisa KekÃ¤lÃ¤inen, Maarit J. Ahava, Raisa Loginov, Hannimari
Kallio-Kokko, Olli Vapalahti, Hanna Jarva, Satu Kurkela, and Maija Lappalainen. 2020.
â€œPerformance of Six SARS-CoV-2 Immunoassays in Comparison with Microneutralisation.â€
medRxivâ€‹, May, 2020.05.18.20101618.
Jiang, Guanmin, Xiaoshuai Ren, Yan Liu, Hongtao Chen, Wei Liu, Zhaowang Guo, Yaqin Zhang, et al.
2020. â€œApplication and Optimization of RT-PCR in Diagnosis of SARS-CoV-2 Infection.â€ m
â€‹ edRxivâ€‹,
February, 2020.02.25.20027755.
Kucirka, Lauren M., Stephen A. Lauer, Oliver Laeyendecker, Denali Boon, and Justin Lessler. 2020.
â€œVariation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reactionâ€“Based
SARS-CoV-2 Tests by Time Since Exposure.â€ A
â€‹ nnals of Internal Medicineâ€‹, May.
https://www.acpjournals.org/doi/abs/10.7326/M20-1495â€‹.
Larremore, Daniel B., Bryan Wilder, Evan Lester, Soraya Shehata, James M. Burke, James A. Hay,
Milind Tambe, Michael J. Mina, and Roy Parker. 2020. â€œTest Sensitivity Is Secondary to Frequency
and Turnaround Time for COVID-19 Surveillance.â€ â€‹medRxiv : The Preprint Server for Health
Sciencesâ€‹, no. medrxiv;2020.06.22.20136309v2 (June).
https://doi.org/â€‹10.1101/2020.06.22.20136309â€‹.
Liu, Yang, Li-Meng Yan, Lagen Wan, Tian-Xin Xiang, Aiping Le, Jia-Ming Liu, Malik Peiris, Leo L. M.
Poon, and Wei Zhang. 2020. â€œViral Dynamics in Mild and Severe Cases of COVID-19.â€ â€‹The Lancet
Infectious Diseasesâ€‹, March. https://doi.org/â€‹10.1016/S1473-3099(20)30232-2â€‹.
Li, Yafang, Lin Yao, Jiawei Li, Lei Chen, Yiyan Song, Zhifang Cai, and Chunhua Yang. 2020. â€œStability
Issues of RT-PCR Testing of SARS-CoV-2 for Hospitalized Patients Clinically Diagnosed with
COVID-19.â€ â€‹Journal of Medical Virologyâ€‹.
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25786?casa_token=G6rAnm1dEaEAAAAA:
Qf4y88NDmqeQIYHyKfQNkkepCgc7ft4EB_IEgTV3Lj-pJ-s7yzi-tsadY_mGA8buqvmPcZavU1Ao6eg
jNQâ€‹.
Lloyd-Smith, J. O., S. J. Schreiber, P. E. Kopp, and W. M. Getz. 2005. â€œSuperspreading and the Effect of
Individual Variation on Disease Emergence.â€ â€‹Natureâ€‹ 438 (7066): 355â€“59.
Niehus, Rene, Pablo M. De Salazar, Aimee R. Taylor, and Marc Lipsitch. 2020. â€œUsing Observational

53

Data to Quantify Bias of Traveller-Derived COVID-19 Prevalence Estimates in Wuhan, China.â€ T
â€‹ he
Lancet Infectious Diseasesâ€‹, April. https://doi.org/â€‹10.1016/S1473-3099(20)30229-2â€‹.
Oran, Daniel P., and Eric J. Topol. 2020. â€œPrevalence of Asymptomatic SARS-CoV-2 Infection: A
Narrative Review.â€ â€‹Annals of Internal Medicineâ€‹, June. https://doi.org/â€‹10.7326/M20-3012â€‹.
Park, Sang Woo, Kaiyuan Sun, David Champredon, Michael Li, Benjamin M. Bolker, David J. D. Earn,
Joshua S. Weitz, Bryan T. Grenfell, and Jonathan Dushoff. 2020. â€œCohort-Based Approach to
Understanding the Roles of Generation and Serial Intervals in Shaping Epidemiological
Dynamics.â€ â€‹Infectious Diseases (except HIV/AIDS)â€‹. medRxiv.
https://doi.org/â€‹10.1101/2020.06.04.20122713â€‹.
Thompson, R. N., J. E. Stockwin, R. D. van Gaalen, J. A. Polonsky, Z. N. Kamvar, P. A. Demarsh, E.
Dahlqwist, et al. 2019. â€œImproved Inference of Time-Varying Reproduction Numbers during
Infectious Disease Outbreaks.â€ E
â€‹ pidemicsâ€‹ 29 (December): 100356.
To, Kelvin Kai-Wang, Owen Tak-Yin Tsang, Wai-Shing Leung, Anthony Raymond Tam, Tak-Chiu Wu,
David Christopher Lung, Cyril Chik-Yan Yip, et al. 2020. â€œTemporal Profiles of Viral Load in
Posterior Oropharyngeal Saliva Samples and Serum Antibody Responses during Infection by
SARS-CoV-2: An Observational Cohort Study.â€ â€‹The Lancet Infectious Diseasesâ€‹, March.
https://doi.org/â€‹10.1016/S1473-3099(20)30196-1â€‹.
Vogels, Chantal B. F., Anderson F. Brito, Anne Louise Wyllie, Joseph R. Fauver, Isabel M. Ott, Chaney
C. Kalinich, Mary E. Petrone, Marie-Louise Landry, Ellen F. Foxman, and Nathan D. Grubaugh.
2020. â€œAnalytical Sensitivity and Efficiency Comparisons of SARS-COV-2 qRT-PCR Assays.â€
medRxivâ€‹.
https://www.medrxiv.org/content/medrxiv/early/2020/04/26/2020.03.30.20048108.full.pdfâ€‹.
Wallinga, Jacco, and Peter Teunis. 2004. â€œDifferent Epidemic Curves for Severe Acute Respiratory
Syndrome Reveal Similar Impacts of Control Measures.â€ A
â€‹ merican Journal of Epidemiologyâ€‹ 160
(6): 509â€“16.
Wallinga, J., and M. Lipsitch. 2007. â€œHow Generation Intervals Shape the Relationship between
Growth Rates and Reproductive Numbers.â€ â€‹Proceedings. Biological Sciences / The Royal Society
274 (1609): 599â€“604.
Wernike, Kerstin, Markus Keller, Franz J. Conraths, Thomas C. Mettenleiter, Martin H. Groschup, and
Martin Beer. 2020. â€œPitfalls in SARS-CoV-2 PCR Diagnostics.â€ T
â€‹ ransboundary and Emerging
Diseasesâ€‹, June. https://doi.org/â€‹10.1111/tbed.13684â€‹.
Whitman, Jeffrey D., Joseph Hiatt, Cody T. Mowery, Brian R. Shy, Ruby Yu, Tori N. Yamamoto, Ujjwal
Rathore, et al. 2020. â€œTest Performance Evaluation of SARS-CoV-2 Serological Assays.â€ Iâ€‹ nfectious
Diseases (except HIV/AIDS)â€‹. medRxiv. https://doi.org/â€‹10.1101/2020.04.25.20074856â€‹.
Wikramaratna, Paul, Robert S. Paton, Mahan Ghafari, and Jose Lourenco. 2020. â€œEstimating
False-Negative Detection Rate of SARS-CoV-2 by RT-PCR.â€ â€‹medRxivâ€‹.
https://www.medrxiv.org/content/10.1101/2020.04.05.20053355v2.abstractâ€‹.
Wu, Joseph T., Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar,
Benjamin J. Cowling, Marc Lipsitch, and Gabriel M. Leung. 2020. â€œEstimating Clinical Severity of
COVID-19 from the Transmission Dynamics in Wuhan, China.â€ â€‹Nature Medicineâ€‹ 26 (4): 506â€“10.
Zhao, Juanjuan, Jr., Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, et al.
2020. â€œAntibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019.â€
Infectious Diseases (except HIV/AIDS)â€‹. medRxiv. https://doi.org/â€‹10.1101/2020.03.02.20030189â€‹.
Zou, Lirong, Feng Ruan, Mingxing Huang, Lijun Liang, Huitao Huang, Zhongsi Hong, Jianxiang Yu, et al.
2020. â€œSARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.â€ â€‹The New
England Journal of Medicineâ€‹ 382 (12): 1177â€“79.

54

